View
1
Download
0
Category
Preview:
Citation preview
HOSTED BY:ORGANISATIONS D’ACCUEIL :
FINAL PROGRAM | PROGRAMME DÉFINITIF
CANADIAN CARDIOVASCULAR CONGRESSCONGRÈS CANADIEN SUR LA SANTÉ CARDIOVASCULAIREOCTOBER 24–27 | MONTRÉAL | 24–27 OCTOBRE
Last updated: October 7, 2019
The Canadian Cardiovascular Society and the Heart and Stroke Foundation, co-hosts of the Canadian Cardiovascular Congress (CCC), gratefully acknowledge the following companies for their educational grants towards the success of CCC 2019 and for their commitment to working with us to build capacity for a strong cardiovascular community in Canada.
La Société canadienne de cardiologie et la Fondation des maladies du cœur et de l’AVC, co-organisateurs du Congrès canadien sur la santé cardiovasculaire (CCSC), tiennent à remercier les entreprises suivantes pour leurs subventions éducatives en vue du succès du CCSC 2019 et pour leur engagement à développer avec nous une communauté cardiovasculaire de grande capacité au Canada.
Industry SupportersCommandites de l’industrie
cardiocongress.org
Industry SupportersThe Canadian Cardiovascular Society and the Heart and Stroke Foundation,
co-hosts of the Canadian Cardiovascular Congress (CCC), gratefully acknowledge the following companies for their educational grants towards the success of CCC 2019 and for their commitment to working together
to build capacity for a strong cardiovascular community in Canada.
PLATINUM
GRAND PATRON
PATRON
CONTRIBUTOR
Last updated: October 7, 2019
The Canadian Cardiovascular Society and the Heart and Stroke Foundation, co-hosts of the Canadian Cardiovascular Congress (CCC), are proud to acknowledge the generous contributions of these not-for-profit health and government agencies. These contributions support overall scientific programme development and delivery for CCC 2019 and demonstrates their commitment to helping us build capacity for a strong cardiovascular community in Canada.
La Société canadienne de cardiologie et la Fondation des maladies du cœur et de l’AVC, co-organisateurs du Congrès canadien sur la santé cardiovasculaire (CCSC), tiennent à reconnaître les organisations sans but lucratif en santé et les agences du gouvernement suivants pour leur généreuse contribution au programme. Ces contributions rendent possibles l’élaboration du programme scientifi que et sa réalisation pendant CCSC 2019 et manifeste votre engagement envers le développement de la capacité de la communauté de la santé cardiovasculaire au Canada.
Programme SupportersCommanditaires du programme
cardiocongress.org
PREMIER GOLD
SILVER
Program SupportersThe Canadian Cardiovascular Society and the Heart and Stroke Foundation,
co-hosts of the Canadian Cardiovascular Congress (CCC), are proud to acknowledge the generous contributions of these not-for-profit health and
government agencies. These contributions support overall scientific program development and delivery for CCC 2019 and demonstrates their commitment to helping us build capacity for a strong cardiovascular community in Canada.
Last updated: October 7, 2019
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Table of Contents Tables des matières
Table of Contents / Tables des matières ………………………………………………………………………. 4
Mobile App / Application mobile …………………………………………………………………………………. 5
Educational Partners / Partenaires en éducation …………………………………………………..…… 6
Canadian Cardiovascular Society Affiliates / Organizations associées de la Société canadienne de cardiologie …………………………………………………………………………………………. 7
Learning Tracks / Parcours d’apprentissage …………………………………….………………………..…. 8
Scientific Programme Committee / Comité du programme scientifique ……………………... 9
Over all Learning Objectives / Objectifs pédagogiques généraux ………………………………. 10
Scientific Program / programme scientif
Thursday, October 24 / jeudi 24 octobre …………………………….………………………….. 11
Friday, October 25 / vendredi 25 octobre …………………………....………………………... 30
Saturday, October 26 / samedi 26 octobre …………………………..………………………... 56
Sunday, October 27 / dimanche 27 octobre …………………….…………..…………....….. 82
Call for Science 2020 / Appel à la science 2020 …………………………………………………………... 90
Last updated: October 7, 2019
4
Programme Information Renseignement sur le programme
Mobile Application
CCC 2019 is at your fingertips for iOS and Android device users. Make the most of your time with the CCC mobile app available for download on the App Store and Google Play: Canadian Cardio Congress
Use the App to:
•viewtheentirescientificprogramme;
•createyourownpersonalschedule;
•makenotesandshareinformationwithcolleagues;
•searchforsessions,presentations,abstracts,participants;
•filterbylearningtrack,byday,bypresentationtitle;
•findexhibitorsandsponsors;
•navigatethefloorplan;and
•jointheconversation!—Twitter #CCCMTL
Application mobile
Les utilisateurs d’appareils iOS ou Android ont un accès facileauCCSC2019.Profitezaumaximumdevotretemps avec l’application mobile CCSC disponible au téléchargement sur App Store et Google Play: Canadian Cardio Congress
Utilisez l’application pour :
•avoirunevueduprogrammescientifique;
•créervotreitinérairepersonnalisé;
•prendredesnotesettransmettredel’information àdescollègues;
•effectuerdesrecherchesparséance,parrésumé, parparticipant;
•utiliserdesfiltresparparcoursd’apprentissage, parjour,partitredeprésentation;
•trouverdesexposantsetdescommanditaires;
•consulterdesplansd’étageet
•participerauxdiscussions!—Twitter #CCCMTL
Back by Popular Demand
Session Participation
Don’t miss your chance to ask questionsdirectlytosessionspeakers during workshops and plenary sessions. Click on the “ARS” icon in the CCC App to find a session and get started.
Don’t have the app? You can still access the event schedule through our online event program.
De retour à la demande générale
Participation à la session
Nemanquezpascettechancedeposervosquestionsdirectement
auxconférencierspendant lesateliersetséancesplénières!
Cliquezsurl’icône«ARS» dans l’application du CCSC pour trouver une séance et
participer à la discussion.
Vous n’avez pas l’appli? Ilestquandmêmepossible
d’accéder à l’horaire des événements par l’entremise du
programme en ligne.
Last updated: October 7, 2019
5
Educational PartnersPartenaires en éducation
Canadian Cardiovascular Society (CCS)Société canadienne de cardiologie (SCC)
Heart and Stroke Foundation (HSF)Fondation des maladies du cœur et de l’AVC (Cœur + AVC)
Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR)Association canadienne de prévention et de réadaptation cardiovasculaires (ACPRC)
Canadian Cardiovascular Society Academy (CCSA)Académie de la Société canadienne de cardiologie (ASCC)
Canadian Council of Cardiovascular Nurses (CCCN)Conseil canadien des infi rmières et infi rmiers en soins cardiovasculaire (CCIISC)
Canadian Society of Cardiology Technologists (CSCT)Société canadienne des technologues en cardiologie (SCTC)
Last updated: October 7, 2019
6
Canadian Cardiovascular Society AffiliatesOrganizations associées de la Société
canadienne de cardiologie
Canadian Adult Congenital Heart Network (CACH) Réseau canadien des cardiopathies congénitales de l’adulte (CCA)
Canadian Association of Interventional Cardiology (CAIC) Association canadienne de cardiologie d’intervention (ACCI)
Canadian Cardiac Transplant Network (CCTN) Réseau canadien de transplantation cardiaque (RCTC)
Canadian Cardiovascular Critical Care Society (CANCARE) Société canadienne pour les soins intensifs cardiovasculaires (SCSIC)
Canadian Heart Failure Society (CHFS) Société canadienne d’insuffisance cardiaque (SCIC)
Canadian Heart Rhythm Society (CHRS) Société canadienne de rythmologie (SCR)
Canadian Pediatric Cardiology Association (CPCA) Association canadienne de cardiologie pédiatrique (ACCP)
Canadian Society of Cardiac Surgeons (CSCS) Société canadienne des chirurgiens cardiaques (SCCC)
Canadian Society of Cardiovascular Magnetic Rsonance (CANSCMR) Société canadienne de résonance magnétique cardiovasculaire (SCRMC)
Canadian Society of Cardiovascular Nuclear & CT Imaging (CNCT) Société canadienne de cardiologie nucléaire et de tomodensitométrie (CNCT))
Canadian Society of Echocardiography (CSE) Société canadienne d’échocardiographie (SCE)
Last updated: October 7, 2019
7
Heart Failure, Heart Function, Cardiomyopathy, Transplant / Insuffisance cardiaque, fonctionnement du cœur, myocardiopathies, greffon
Hypertension / Hypertension artérielle
Imaging Techniques, Nuclear Cardiology, MRI, Echo / Techniques d’imagerie, cardiologie nucléaire, IRM, échocardiographie
Nursing / Soins infirmiers
Prevention / Prévention
Quality improvement, healthcare policy and administration related to cardiovascular sciences / Amélioration de la qualité, politique et administration des soins de santé dans le domaine des sciences cardiovasculaires
Cardiac Surgery and Anesthesia / Chirurgie cardiaque, anesthésie
Vascular disease and vascular complications of diabetes and obesity specifically affecting the non-coronary vasculature, such as the cerebral arteries, lower extremity arteries, aorta, or pulmonary arteries / Maladies vasculaires et complications vasculaires du diabète et de l’obésité touchant spécifiquement la vasculature autre que coronaire, telles les artères cérébrales, les extrémités inférieures, l’aorte ou les artères pulmonaires.
PROGRAMME INFORMATION / RENSEIGNEMENT SuR LE PROGRAMME
Parcours d’apprentissage
Les parcours d’apprentissage permettent de cerner les contenus offerts. Selon les sujets abordés, certaines séances correspondront dans certains cas à plus d’un parcours.
Ils sont associés aux séances suivantes :
•séancesplénières;
•ateliersetséancesvedettes;
•présentationsderésumés(affichesélectroniques,présentationsoralesetdirigées);et
•symposiumsagréés.
Learning Tracks
Learning tracks isolate specific programme content. Depending on the topic, or focus, certain sessions may have more than one learning track associated to them.
Learning tracks are assigned to:
•Plenarysessions;
•Workshopsandspotlights;
•Abstractsessions(ePosters,moderatedpresentationsandorals);and
•Accreditedsymposia.
Atherosclerosis, Basic Vascular / Athérosclérose, affection vascularie de base
Chronic Coronary Artery Disease / Maladie coronarienne chronique
ACS, AMI, Critical care for cardiovascular diseases / Syndrome coronarien aigu (SCA), infarctus aigu du myocarde (IAM), soins critiques pour les maladies cardiovasculaires
Pediatrics and Congenital Heart Disease / Cardiologie pédiatrique et cardiopathies congénitales
Coronary and Structural Intervention, PCI, Interventional procedures / Intervention coronaire et structurelle, ICP, procédures interventionnelles
Electrophysiology, Sudden Cardiac Death, Arrhythmology / Électrophysiologie, mort subite d’origine cardiaque, arythmologie
The process of educational learning and dissemination of knowledge or skills relevant to cardiovascular sciences / Le processus d’apprentissage et de partage des connaissances et compétences pertinentes au domaine cardiovasculaire
ASO HF
HTN
IMAG
PREV
NuRS
PLCY
SuRG
VASC
CAD ACS AMI
CAD GEN
CSI
CONG
EP
EDu
There are 15 learning tracks, each with a corresponding icon. Listed alphabetically, they are identified as follows:
On compte 15 parcours d’apprentissage, chacun étant indiqué par un icône particulier. Les parcours sont les suivants (par ordre alphabétique anglais) :
Last updated: October 7, 2019
8
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Scientific Program Committee Comité du programme scientific
Thank you to the many committee members and volunteers who have helped make CCC 2019 a success. Visit www.cardiocongress.org and www.ccs.ca for full committee listings.
Anique Ducharme Scientific Program Committee Chair, Featured Research Committee, Workshop Committee, Community Cardiology Committee
Kenneth Gin Annual Meeting Chair
Michelle Graham Outgoing Scientific Program Committee Chair, Stump the Experts Co‐chair
Simon Jackson Incoming Annual Meeting Chair
Christopher Franco Track Captain ‐ ASO
John Parker Track Captain ‐ CAD (ACS & AMI/General), CAD/INT, Young Investigator Award Committee
Frédéric Dallaire Track Captain – CONG, Workshop Committee
Bradley Strauss Track Captain – CSI, Young Investigator Award Committee
Matthew Bennett Track Captain ‐ EP (Basic & Clinical), Featured Research Committee Chair
Nowell Fine Track Captain – HF, Featured Research Committee
Wendy Tsang Track Captain – IMAG, PLCY, Featured Research Committee
Sandra Pelaez Track Captain ‐ PREV, CACPR Representative
Sheldon Tobe Track Captain ‐ HTN (Basic)
Denis Bouchard Track Captain ‐ SURG
Nicolas Thibodeau‐Jarry Track Captain ‐ EDU
Sean McMurtry Track Captain – Vascular, Workshop Committee
Susan Morris Track Captain – Nursing, Workshop Committee, CCCN Representative
David Bewick Community Cardiology Committee Chair, Workshop Committee
Jean Grégoire Community Cardiology Committee
Nathaniel Moulson Community Cardiology Committee
Guillaume Marquis‐Gravel Community Cardiology Committee
Christopher Cheung Trainee Program Committee Co‐chair, Stump the Experts Co‐chair
Claudia Coté Trainee Program Committee Co‐chair, Workshop Committee
Chi‐Ming Chow Workshop Committee Chair
Joselyn Dupuis Young Investigator Award Chair
Sharon Chih Trainee Research Award Committee Chair
Cindy Yip HSF Representative
Diane Forbes CIHR ‐ ICRH Representative
Karen Schaus CSCT Representative
Last updated: October 7, 2019
9
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
What is the Canadian Cardiovascular Congress? The Canadian Cardiovascular Congress (CCC) is the largest gathering of cardiovascular and allied health professionals in Canada. The Congress draws cardiologists, cardiovascular surgeons, researchers, nurses and other cardiovascular specialists from across Canada and around the globe and connects them with other members of the cardiovascular healthcare team. The CCC provides a broad spectrum of cardiovascular health professionals with current scientific information, accredited education opportunities and an ideal forum to connect with other cardiovascular health and care colleagues. This annual congress unites Canada’s cardiovascular community, from physicians to researchers, to network, learn and showcase the latest in research and innovations. CCC Objectives
1. Strengthen the Canadian cardiovascular care community.
2. Promote Canadian perspectives on cardiovascular sciences to a global audience.
3. Enhance opportunities for professional collaboration and networking.
4. Offer a highly visible platform to showcase research from early career investigators.
5. Develop the next generation of cardiovascular care leaders through mentorship and network growth.
6. Provide a forum for the discussion of public policy to strengthen cardiovascular care in Canada.
Qu’est‐ce que le Congrès canadien sur la santé cardiovasculaire? Le Congrès canadien sur la santé cardiovasculaire (CCSC) est la rencontre la plus importante de professionnels de la santé cardiovasculaire et de spécialistes dans des domaines connexes au Canada. Le Congrès attire des cardiologues, des chirurgiens cardiovasculaires, des chercheurs, des infirmières et infirmiers et d'autres spécialistes cardiovasculaires de partout au Canada et dans le monde, et les met en contact avec d'autres membres de l'équipe de soins de santé cardiovasculaires. Le CCSC fournit un large spectre de professionnels de la santé cardiovasculaire avec de l'information scientifique courante, des occasions d'enseignement accrédité et un forum idéal pour se brancher à d'autres collègues de soins et de santé cardiovasculaire. Ce congrès annuel réunit la communauté des professionnels de la santé cardiovasculaire, des médecins aux chercheurs, afin de leur permettre de réseauter, tout en découvrant et en présentant les nouveautés en recherche et les dernières innovations. Objectifs de la SCC
1. Renforcer la communauté des soins cardiovasculaires au Canada.
2. Promouvoir le point de vue canadien en sciences cardiovasculaires auprès d’un public mondial.
3. Améliorer les possibilités de collaboration professionnelle et de réseautage.
4. Offrir une plateforme hautement visible afin de mettre en valeur les recherches de scientifiques en
début de carrière.
5. Développer la prochaine génération de chefs de file en soins cardiovasculaires par le mentorat et la
croissance des réseaux.
6. Offrir un forum de discussion sur les politiques publiques destiné à renforcer les soins
cardiovasculaires au Canada.
Last updated: October 7, 2019
10
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
08:00 ‐ 08:30
Networking
HOW TO NAVIGATE THE CCC
COMMENT NAVIGUER AU SEIN DU CCSC
NETWORKING
Community Forum Lobby, Level 200
First time to CCC? First time using the CCC App? Drop in and find out what’s new at CCC!
08:30 ‐ 10:00
Plenary
CANADIAN CARDIOVASCULAR CONGRESS OPENING KICK‐OFF SESSION
SÉANCE D'INAUGURATION DU CONGRÈS CANADIEN SUR LA SANTÉ CARDIOVASCULAIRE
GENERAL SI
220CDE ‐ Plenary Room via CF
Co‐Chairs: Anique Ducharme Kenneth Gin
Target Audience: General: All cardiovascular (clinical and research) health professionals
08:30
LEADERSHIP
Keynote Speaker: Gigi Osler Winnipeg, Manitoba
09:30 ‐ 17:00
Networking
CCC 2019 COMMUNITY FORUM OPEN
OUVERTURE DU FORUM COMMUNAUTAIRE DU CCSC 2019
NETWORKING
Community Forum, Level 200
Visit the CCC 2019 Community Forum with ePosters, Moderated Presentations, Affiliate Limelight Sessions, Community Forum Theater Sessions, the MIT Lounge, the FCCS Lounge, the Nurses Corner, and our amazing CCC 2019 Exhibitors!
10:00 ‐ 10:30 HEALTH BREAK AND EXHIBITION
PAUSE SANTÉ ET EXPOSITION
NETWORKING
Community Forum, Level 200
10:00 ‐ 10:30
Networking
HOW TO NAVIGATE THE CCC
COMMENT NAVIGUER AU SEIN DU CCSC
NETWORKING
Community Forum Lobby, Level 200
First time to CCC? First time using the CCC App? Drop in and find out what’s new at CCC!
10:30 ‐ 11:30
Workshop
A SESSION FOR ECG LOVERS
UNE SÉANCE POUR LES AMATEURS D'ECG
Last updated: October 7, 2019
11
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
EP EDU
520CF
Faculty: Adrian Baranchuk George Veenhuyzen Peter Guerra Martin Green
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
to recognize supraventricular tachycardias, WPW ECG pattern and Wenckebach phenomenon;
identify the most common ECG presentations of Lyme carditis; and
to determine when Wenckebach phenomenon requires treatment, when WPW ECG pattern requires invasive management and when Lyme carditis requires pacing.
10:30 ‐ 11:30
Workshop
MY WORST ARRHYTHMIA NIGHTMARE 2019 WORKSHOP
ATELIER MON PIRE CAUCHEMAR D’ARYTHMIE 2019
EP HF
520AD
Faculty: Laurent Macle Jason Andrade John Sapp Bernard Thibault
Target Audience: Clinical cardiologists Trainee (clinical) Electrophysiologists
Learning Objectives At the end of this session participants will be able to:
evaluate and manage patients with non sustained ventricular tachycardia and newly diagnosed dilated cardiomyopathy with severe left ventricular dysfunction;
interpret the ECG of patients with conduction disturbances in the context of acute myocardial infarction and identify the need for pacing; and
evaluate patients with AV conduction disorders (limiting optimisation of medical treatment or requiring pacing), moderate LV dysfunction (LVEF 35‐40%) and narrow QRS.
10:30 ‐ 11:30
Workshop
MY WORST ECHO NIGHTMARE IV: CASES FROM COAST TO COAST
MON PIRE CAUCHEMAR D’ÉCHOGRAPHIE IV : DES CAS DES QUATRE COINS DU PAYS
IMAG CAD ACS & AMI
522
Last updated: October 7, 2019
12
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Faculty: Sabe De David Bewick Bibiana Cujec Nowell Fine Jasmine Grewal Christine Henri Davinder Jassal David McCarty Gillian Nesbitt Igal Sebag Howard Leong‐Poi Usha Manian Sarah Ramer
Target Audience: Academic cardiovascular health professionals and researchers Trainee (clinical) General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
assess valvular abnormalities diagnosed on echocardiography and the acute management of such lesions in emergent settings;
recognize cardiovascular emergencies (tamponade, aortic dissection, thrombus) that require immediate diagnosis and clinical attention; and
describe recognized life threatening complications of myocardial infarction and appropriate diagnosis and interventions.
10:30 ‐ 12:00
Plenary
CPCA/CACH JOINT SYMPOSIUM I: CONTROVERSIES IN PEDIATRIC AND ADULT CONGENITAL HEART DISEASE
SYMPOSIUM CONJOINT DE L'ACCP ET DU RCCCA I : DÉBATS EN CARDIOPATHIE CONGÉNITALE CHEZ L'ENFANT ET CHEZ L'ADULTE
CONG CPCA CACH
518C
Co‐Chairs: Derek Human Isabelle Vonder Muhll
10:35
TO ROSS OR NOT TO ROSS (PRO SIDE): THE ROSS PROCEDURE SHOULD BE THE NORM FOR SEVERE AORTIC STENOSIS IN CHILDREN AND YOUNG ADULTS
Presenter: Jean Perron
10:55
TO ROSS OR NOT TO ROSS (CON SIDE): THE ROSS PROCEDURE SHOULD BE THE EXCEPTION FOR SEVERE AORTIC STENOSIS IN CHILDREN AND YOUNG ADULTS
Presenter: Luis G. Quinonez
11:20
EXERCISE RESTRICTION IN CHD (PRO): EXERCISE RESTRICTION SHOULD BE THE NORM FOR COMPLEX CONGENITAL HEART DISEASE
Last updated: October 7, 2019
13
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Presenter: Charles Rohlicek
11:40
EXERCISE RESTRICTION IN CHD (CON): EXERCISE RESTRICTION SHOULD BE THE EXCEPTION FOR COMPLEX CONGENITAL HEART DISEASE
Presenter: Barbara Cifra
10:30 ‐ 12:00
Plenary
FEATURED RESEARCH SESSION
SÉANCE DE RECHERCHE MISE EN VALEUR
IMG HTN HF
520BE
Chair: Karin Humphries
10:30
TRIALS AND TALES FROM A TROPONIN ENTHUSIAST
Keynote Speaker: Nicholas Mills Edinburg, United Kingdom
11:00
THE HEART OUTCOMES PREVENTION EVALUATION 4 CANADA: A PILOT STUDY OF A COMMUNITY‐BASED, MULTI‐FACETED INTERVENTION, LED BY NON‐PHYSICIANS TO REDUCE CARDIOVASCULAR RISK IN PEOPLE WITH HYPERTENSION
JD Schwalm Hamilton, Ontario
11:15
HEART‐FOCUSED IONIZING RADIATION INDUCED DNA DAMAGE ACTIVATES INFLAMMATION VIA CGAS‐STING PATHWAY LEADING TO CARDIAC REMODELING AND HEART FAILURE
Mohammad H. Al‐Khalaf Ottawa, Ontario
11:30
IMPACT OF SEX AND LOW‐FLOW ON SURVIVAL AFTER AORTIC VALVE REPLACEMENT FOR SEVERE AORTIC STENOSIS AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION
Ezequiel Guzzetti Québec, Québec
10:30 ‐ 12:00
Plenary
FEEL BETTER, WORK BETTER: EQ CARDIAC SCIENCES
SE SENTIR MIEUX, MIEUX TRAVAILLER : LA NOTION D'INTELLIGENCE ÉMOTIONNELLE EN SCIENCES CARDIAQUES
GENERAL CANMEDS
517C
Chair: Sarah Ramer
Target Audience: General: All cardiovascular (clinical and research) health professionals
Last updated: October 7, 2019
14
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Learning Objectives At the end of this session participants will be able to:
discuss prevalence of burnout in the cardiac sciences from physician and nursing perspectives. Discuss methods of burnout prevention;
career transitions can be particularly difficult. Strategies to successfully transition in both early and late career will be discussed; and
time management is a common struggle in cardiac sciences. Methods to manage busy career and family obligations will be discussed.
10:30
CAREER TRANSITIONS
Panelists: Christopher Fordyce Vancourver, British Columbia
John Parker Toronto, Ontario
10:30
STRESS AND BURNOUT IN CV HEALTHCARE FIELD
Panelists: Susan Morris Saint John, New Brunswick
Chris Simpson Kingstson, Ontario
10:30
TIME MANAGEMENT
Panelist: Catherine Kells Halifax, Nova Scotia
10:30 ‐ 12:00
Plenary
SCIENTIFIC PROGRAM COMMITTEE (SPC) PLENARY SESSION: CARDIOGENIC SHOCK ‐ A HEART TEAM APPROACH
SÉANCE PLÉNIÈRE DU COMITÉ DU PROGRAMME SCIENTIFIQUE : LE CHOC CARDIOGÉNIQUE, UNE APPROCHE AXÉE SUR UNE ÉQUIPE DE CARDIOLOGIE
HF SURG TRAINEE
517D
Co‐Chairs: Yoan Lamarche Shelley Zieroth
Presenters: Claudia Côté Halifax, Nova Scotia Omid Kiamanesh Vancouver, British Columbia Panelists: Sharon Chih Ottawa, Ontario Daniel Kim Edmonton, Alberta Dave Nagpal London, Ontario Valérie Rodgers
Last updated: October 7, 2019
15
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Chambly, Québec
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
describes tools in evaluating the severity of shock;
compare algorithms for coronary or non‐coronary cardiogenic shock; and
describe successes in developing a cardiogenic shock team.
12:00 ‐ 14:00 LUNCH BREAK, EPOSTER VIEWING, COMMUNITY FORUM THEATRE AND EXHIBITION
PAUSE DÎNER, VISIONNEMENT DES AFFICHES ÉLECTRONIQUES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
12:30 ‐ 13:30
Accredited Symposium
ABCD OF ATTR AMYLOIDOSIS ‐ A PRACTICAL APPROACH: ATTR AMYLOIDOSIS BEST PRACTICES FOR CARE AND DIAGNOSIS
ABCD DE L'AMYLOÏDOSE ATTR : UNE APPROCHE PRATIQUE : PRATIQUES OPTIMALES EN SOINS ET DIAGNOSTIC D'AMYLOÏDOSE ATTR
HF IMAG
EDU CLINICAL CARDIOLOGY
517C
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was developed by the Canadian Heart Failure Society and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through educational grants from Akcea, Alnylam, and Pfizer Canada.
Click here to view the program!
Co‐Chairs: Shelley Zieroth Anique Ducharme
Target Audience: Cardiac technicians & nurses Clinical cardiologists Heart failure specialists Learning Objectives At the end of this session participants will be able to:
improve the recognition of ATTR amyloidosis and acknowledge how early diagnosis is associated with better outcomes;
apply best practices for the diagnosis and treatment of ATTR amyloidosis;
understand the importance of a coordinated multidisciplinary care approach; and
define the optimal treatment paradigms for ATTR amyloidosis, including clinical, imaging, or serum biomarker strategies.
Last updated: October 7, 2019
16
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
12:30
WELCOME AND INTRODUCTIONS
12:35
EMERGING STRATEGIES TO TREAT AND MANAGE AMYLOIDOSIS
Presenter: Sarah Cuddy
Learning Objectives At the end of this session participants will be able to:
describe novel therapeutic strategies for ATTR amyloidosis
12:55
USING IMAGING TO GUIDE THERAPY IN CARDIAC AMYLOIDOSIS
Presenter: Jeroen Bax
Learning Objectives At the end of this session participants will be able to:
describe imaging modalities for the diagnosis and treatment of cardiac amyloidosis
13:05
WHEN ATTR GETS ON YOUR NERVES: A PRIMER ON ATTR NEUROLOGIC INVOLVEMENT FOR CARDIOLOGISTS
Presenter: Vera Bril
Learning Objectives At the end of this session participants will be able to:
understand the effect of ATTR amyloidosis on the nervous system and recognize
when to refer to a neurologist and geneticist
13:15
CCS‐CHFS POSITION PAPER ON AMYLOIDOSIS
Presenter: Margot Davis
Learning Objectives At the end of this session participants will be able to:
discuss contemporary data and evidence in the context of the Canadian healthcare system
13:25 CLOSING REMARKS
12:30 ‐ 13:30
Accredited Symposium
OPTIMIZING ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION ‐ EXPERTS ON THE CASE
TROUVER LE TRAITEMENT ANTITHROMBOTIQUE OPTIMAL CHEZ LES PATIENTS ATTEINTS DE FIBRILLATION AURICULAIRE – LES EXPERTS SE PRONONCENT
EP EDU CAD ACS & AMI CLINICAL CARDIOLOGY
517D
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was co‐developed with the Canadian Cardiovascular
Last updated: October 7, 2019
17
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Society and BMS/Pfizer Alliance and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through an educational grant from BMS/Pfizer Alliance.
Click here to view the program!
Co‐Chairs: Jason Andrade Laurent Macle
Presenters: Paul Dorian Shaun Goodman Isabelle Nault
Planning Committee Members: Isabelle Nault Paul Dorian Shaun Goodman
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
identify the optimal antithrombotic treatment strategy for AF patients with ACS/PCI; and
describe the efficacy and safety of oral anticoagulation therapy for stroke prevention in AF patients at higher risk of stroke and bleeding.
12:30
OPENING REMARKS
Presenter: Laurent Macle
12:35
ORAL ANTICOAGULATION IN ACS/PCI
Presenter: Shaun Goodman
Learning Objectives At the end of this session participants will be able to:
describe the evidence supporting the different combinations of oral anticoagulants and antiplatelet agents for AF patients in the context of ACS or PCI.
12:50
QUESTION PERIOD
13:05
ANTICOAGULATION MANAGEMENT IN THE COMPLEX, ELDERLY PATIENT
Presenter: Isabelle Nault
Learning Objectives At the end of this session participants will be able to:
identify the risks and benefits of oral anticoagulation therapy for the complex elderly AF patient.
13:15
ANTICOAGULATION MANAGEMENT IN PATIENTS WITH A RISK OF GI BLEEDING
Presenter: Paul Dorian
Learning Objectives At the end of this session participants will be able to:
Last updated: October 7, 2019
18
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
examine the optimal stroke prevention strategy for AF patients at higher risk or with a history of bleeding.
13:25
QUESTION PERIOD
13:30
CLOSING REMARKS
Presenter: Laurent Macle
14:00 ‐ 15:30
Plenary
RESEARCH ACHIEVEMENT AWARD
PRIX D’EXCELLENCE EN RECHERCHE
RESEARCH AWARD
520BE
Chair: Anthony Tang
Keynote Speaker: Ruth McPherson
Target Audience: Academic cardiovascular health professionals and researchers Basic scientists
14:00 ‐ 15:30 POINT OF CARE ULTRASOUND FOR THE TRAINEE
L'ÉCHOGRAPHIE CIBLÉE POUR LES STAGIAIRES
TRAINEE GENERAL
524C
Faculty: Amer Johri Kingston, Ontario Christina Luong Vancouver, British Columbia
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
develop an understanding of POCUS and its use in the clinical setting;
obtain useful images of the heart, lungs, and IVC to facilitate clinical decision‐making; and
differentiate between normal and abnormal findings using POCUS; and
Apply your knowledge to simulated clinical cases.
14:00 ‐ 15:30 SURGICAL SKILLS: BEGINNER
COMPÉTENCES CHIRURGICALES – NIVEAU DÉBUTANT
TRAINEE SURGICAL
524A
Target Audience: Cardiac surgery residents only Trainee (clinical)
14:00 ‐ 15:30
Guidelines
Last updated: October 7, 2019
19
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
A PRACTICAL CASE‐BASED WORKSHOP ON THE 2018 FOCUSED UPDATE OF THE CCS GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION
ATELIER D'HISTOIRE DE CAS SUR LA MISE À JOUR CIBLÉE 2019 DES LIGNES DIRECTRICES DE LA SCC SUR LA PRISE EN CHARGE DE LA FIBRILLATION VENTRICULAIRE
EP CAD GEN CHRS
220CDE ‐ Plenary Room via CF
Faculty: Laurent Macle Jason Andrade Atul Verma L. Brent Mitchell Allan Skanes
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
Learning Objectives At the end of this session participants will be able to:
align clinical practice with the CCS's atrial fibrillation guidelines with the review antithrombotic management of patients with atrial fibrillation and coronary artery disease;
identify which patients with AF and Heart Failure may benefit from catheter ablation; and
discuss the latest evidence in stroke prevention for atrial fibrillation patients undergoing cardioversion.
14:00 ‐ 15:30
Plenary
CANADIAN JOURNAL OF CARDIOLOGY PLENARY: EMERGING THEMES IN AMYLOID HEART DISEASE
PLÉNIÈRE DU JOURNAL CANADIEN DE CARDIOLOGIE : NOUVEAUX THÈMES EN CARDIOPATHIE AMYLOÏDE
HF EP IMAG CJC
517D
Chair: Stanley Nattel
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
understand the differences between the main forms of cardiac amyloidosis;
learn how to avoid the pitfalls in recognizing and diagnosing amyloidosis; and
update recent breakthroughs in amyloidosis management and learn how to apply them; and
gain an understanding of the presentations, mechanisms and management of arrhythmias associated with cardiac amyloidosis.
14:00
Last updated: October 7, 2019
20
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
CARDIAC AMYLOIDOSIS, AN EMERGING EPIDEMIC ‐ EPIDEMIOLOGY AND CLINICAL PRESENTATION
Presenter: Diego Delgado Toronto, ON, Ontario
14:20
CHALLENGES AND STRATEGIES IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS
Presenter: Nowell Fine Calgary, Alberta
14:40
RECENT BREAKTHROUGHS IN THE TREATMENT OF CARDIAC AMYLOIDOSIS
Presenter: Sarah Cuddy Brigham and Women's Hospital
15:00
AMYLOIDOSIS‐ASSOCIATED CARDIAC ARRHYTHMIAS AND THROMBOEMBOLISM ‐ CONTROVERSIES AND APPROACHES
Presenter: Margot Davis Vancouver, British Columbia
14:00 ‐ 15:30
Plenary
CPCA SCIENTIFIC SESSION I ‐ NEW AND NOT SO NEW FUNCTIONAL ECHOCARDIOGRAPHIC MODALITIES IN PEDIATRICS
SÉANCE SCIENTIFIQUE I DE L’ACCP : LES NOUVELLES ET PAS SI NOUVELLES MODALITÉS
D'ÉCHOCARDIOGRAPHIE FONCTIONNELLE EN PÉDIATRIE
CONG CPCA
518C
Co‐Chairs: Michael Grattan Nee Scze Khoo
Target Audience: Pediatric cardiologists Electrophysiologists
14:00
ENTERING THE MATRIX: ECHOCARDIOGRAPHY IN THE ERA OF HIGH FRAME RATE IMAGING
Presenter: Wadi Mawad
14:20
WHERE DO WE STAND (OR CYCLE OR RUN) ON EXERCISE ECHOCARDIOGRAPHY IN PEDIATRICS
Presenter: Barbara Cifra
14:40
HARNESSING ARTIFICIAL INTELLIGENCE IN PEDIATRIC ECHOCARDIOGRAPHY
Presenter: Jan Dhooge Leuven, Belgium KU Leuven
15:05
Last updated: October 7, 2019
21
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
ADVANCED FUNCTIONAL ECHOCARDIOGRAPHY IMAGING YOU SHOULD ALREADY BE USING IN CLINIC
Presenter: Luc Mertens
14:00 ‐ 15:30
CHRS ALLIED HEALTH EDUCATION SESSION
SÉANCE DE FORMATION DU PERSONNEL PARAMÉDICAL DE LA SCR
EP CHRS
522
Moderators: Jacqueline Forman Debra Campbell Stefanie MacLeod
Target Audience: General: All cardiovascular (clinical and research) health professionals Cardiac technicians and nurses
14:00
POST SURGICAL ABLATION: FINDING THE RIGHT PATH IN POST DISCHARGE FOLLOW‐UP
Presenter: Belinda‐Ann Furlan
Learning Objectives At the end of this session participants will be able to:
describe the development process and outline the post surgical AF ablation care pathway, which will provide the ability to track the following outcomes: AF burden, post‐operative complications,
requirement of anti‐arrhythmics, repeat rhythm control procedures; and symptom and quality of life scores; and
understand patient experiences post pathway implementation and plans for future evaluation.
14:15
SUDDEN DEATH PREVENTION IN HYPERTROPHIC CARDIOMYOPATHY – AN ADOLESCENT PERSPECTIVE
Presenter: Rebecca Hart
Learning Objectives At the end of this session participants will be able to:
gain an awareness of the unique challenges of monitoring and treating adolescents with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death; and
identify a patient‐centred approach to the multi‐disciplinary care, treatment and education of adolescent patients living with hypertrophic cardiomyopathy.
14:30
HIS BUNDLE PACING: RESURGENCE OF A LEGACY TECHNIQUE WITH MODERN TOOLS
Presenter: Andrew Mardell
Learning Objectives At the end of this session participants will be able to:
identify the pathophysiology of heart failure related to right bundle branch block; and
Last updated: October 7, 2019
22
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
identify selective His Bundle pacing with and without sequestration of the right bundle and understand the options available using multisite pacing.
14:45
PAD CHOICE IN CARDIOVERSION FOR ATRIAL FIBRILLATION (PACC‐AF)
Presenter: Dina Cutting
Learning Objectives At the end of this session participants will be able to:
identify which of the four pad types provided the best success rates; and
understand whether potential factors such as age, gender, BMI, use of anti‐arrhythmic drugs were also influential in cardioversion success rates.
15:00
THE DEVELOPMENT OF CANADIAN ATRIAL FIBRILLATION CLINIC NURSING ALLIANCE
Presenter: Jennifer Cruz
Learning Objectives At the end of this session participants will be able to:
understand the step by step creation of CAFcNA with highlights from previous and current projects of group members; and
provide an interactive audience engagement to explore future plans and consideration of a patient education program within AF clinics.
15:15
INTERESTING CASES IN DEVICE CLINIC FOLLOW‐UP
Presenter: Katrina Kosmowski
Learning Objectives At the end of this session participants will be able to:
understand device clinic follow‐up of patients with HIS bundle pacing technology and the clinical factors which should be considered in utilizing subcutaneous defibrillators in young patients; and
share the experience with utilizing a combination transvenous pacemaker and subcutaneous defibrillator for patient therapy.
14:00 ‐ 15:30
Workshop
CANADIAN ASSOCIATION OF INTERVENTIONAL CARDIOLOGY SPOTLIGHT: CAIC'S CONTROVERSIES IN CARDIAC INTERVENTIONS
SÉANCE VEDETTE DE L'ASSOCIATION CANADIENNE DE CARDIOLOGIE D’INTERVENTION : LES DÉBATS DE L'ACCI EN INTERVENTIONS CARDIOVASCULAIRES
CAD GEN CAIC CAD ACS & AMI
517C
Faculty: Donald Palisaitis Dean Traboulsi Sam Radhakrishnan Hung Ly
Last updated: October 7, 2019
23
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Target Audience: Interventional cardiologists Academic cardiovascular health professionals and researchers General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
evaluate and critique controversial techniques and decision‐making during cardiac interventions;
challenge conventional thinking and approaches during cardiac interventions; and
identify controversies in the utilization of adjunctive therapies during cardiac interventions.
14:00 ‐ 15:30
Workshop
CANADIAN CARDIOVASCULAR CRITICAL CARE SOCIETY SPOTLIGHT: CANCARE CUP 2019: CARDIAC CRITICAL. CARE JEOPARDY
SÉANCE VEDETTE DE LA SOCIÉTÉ CANADIENNE POUR LES SOINS INTENSIFS CARDIOVASCULAIRES : LA COUPE 2019 DE LA SOCIÉTÉ CANADIENNE POUR LES SOINS INTENSIFS CARDIOVASCULAIRES : LE JEU‐QUESTIONNAIRE JEOPARDY DES SOINS AUX MALADES EN PHASE CRITIQUE.
SURG CANCARE CAD GEN
520CF
Faculty: Gurmeet Singh
Sean Van Diepen Shelley Zieroth Rachel Eikelboom Vincent Chauvette Mia Bertic Ansar Hassan Jean‐Francois Légaré Abby White Michelle Graham Lior Bibas Erin Rayner‐Hartley Katia Dyrda Richard Vandegriend Anique Ducharme
Target Audience: Critical care cardiologists and specialists General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
identify and describe treatment approaches to advanced heart failure and cardiogenic shock;
identify and treat common and critical dysrhythmias; and
identify and troubleshoot complications of mechanical ventilation.
14:00 ‐ 15:30
Workshop
CANADIAN SOCIETY OF CARDIOVASCULAR MAGNETIC RESONANCE SPOTLIGHT: CHARACTERIZING MYOCARDIAL TISSUE; A VALUE‐ADD FROM CARDIAC MAGNETIC RESONANCE
Last updated: October 7, 2019
24
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
SÉANCE VEDETTE DE LA SOCIÉTÉ CANADIENNE DE CARDIOLOGIE NUCLÉAIRE ET DE TOMODENSITOMÉTRIE : NOUVELLES FRONTIÈRES EN IMAGERIE CARDIAQUE POUR L'INSUFFISANCE CARDIAQUE
IMAG CANSCMR
520AD
Faculty: Idan Roifman Kim Connelly Bradley Sarak Kate Hanneman Andrew Yan Andreas Kumar Djeven Deva James White Ian Paterson Craig Butler
Target Audience: General: All cardiovascular (clinical and research) health professionals Magnetic imaging specialist Researchers
Learning Objectives At the end of this session participants will be able to:
define the term ‘tissue characterization’ and understand the commonly used CMR tissue characterization techniques (late gadolinium enhancement, T1, T2 and T2* mapping) including their advantages and limitations;
understand which tissue characterization technique is appropriate to use in various disease states including cardiomyopathy, diabetes and coronary artery disease; and
evaluate the evidence base linking tissue characterization parameters to downstream patient outcomes.
15:30 ‐ 16:30 WELCOME RECEPTION, EPOSTER PRESENTATIONS, MODERATED PRESENTATIONS, COMMUNITY FORUM THEATRE AND EXHIBITION
RÉCEPTION DE BIENVENUE, PRÉSENTATIONS DES AFFICHES ÉLECTRONIQUES, PRÉSENTATIONS DIRIGÉES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
16:30 ‐ 17:30 COMMUNITY CARDIOLOGY: WHAT'S INVOLVED IN A COMMUNITY PRACTICE
CARDIOLOGIE EN MILIEU EXTRAHOSPITALIER : LES RÉALITÉS D'UN CABINET EN MILIEU EXTRAHOSPITALIER
TRAINEE GENERAL
524C
Faculty: David Bewick Saint John, New Brunswick Joel Niznick Ottawa, Ontario
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
Last updated: October 7, 2019
25
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
understand the challenges and benefits of a community cardiology practice;
learn how a community practice operates and what it can offer you; and
appreciate important aspects of a community practice before starting or joining one.
16:30 ‐ 17:30 ECG FOR BEGINNERS
L'ECG POUR DÉBUTANTS
TRAINEE CARDIOLOGY
524B
Faculty: Adrian Baranchuk Kingston, Ontario
Target Audience: Trainee (clinical)
16:30 ‐ 17:30 SURGICAL SKILLS: ADVANCED
COMPÉTENCES CHIRURGICALES – NIVEAU AVANCÉ
TRAINEE SURGICAL
524A
Faculty: Richard Cook Vancouver, British Columbia
David Horne Halifax, Nova Scotia
Target Audience: Cardiac surgery residents only
16:30 ‐ 17:30
Guidelines
CCS HEART FAILURE GUIDELINES: CLINICAL TRIALS UPDATE
LIGNES DIRECTRICES SUR L’INSUFFISANCE CARDIAQUE DE LA SCC : MISE À JOUR DES ESSAIS CLINIQUES
HF CHFS
220CDE ‐ Plenary Room via CF
Faculty: Eileen O'Meara Michael McDonald Anique Ducharme Mustafa Toma Jonathan Howlett Sean Virani
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
Learning Objectives At the end of this session participants will be able to:
discuss the multidisciplinary approach for the evaluation and care of PMVR candidates;
define the role of novel pharmacologic therapies for ATTR cardiac amyloidosis; and
discuss the evolving role of SGLT2 inhibitors for the prevention and management of patients with HF.
16:30 ‐ 17:30
Plenary
Last updated: October 7, 2019
26
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
CPCA SCIENTIFIC SESSION II ‐ PREVENTIVE CARDIOLOGY IN CHILDREN AND ADOLESCENTS
SÉANCE SCIENTIFIQUE II DE L’ACCP : LA CARDIOLOGIE PRÉVENTIVE CHEZ LES ENFANTS ET LES ADOLESCENTS
CONG CPCA
518C
Chair: Christian Drolet
Target Audience: Pediatric cardiologists
16:30
CARDIOVASCULAR RISK IN CHILDREN WITH ACQUIRED AND CONGENITAL HEART DISEASE: WHO IS AT RISK AND WHEN TO LOOK FOR IT
Presenter: Jean‐Luc Bigras Montréal, Québec
16:50
TREATING DYSLIPIDEMIA, HYPERTENSION, AND OBESITY IN CHILDREN WITH PEDIATRIC CONGENITAL DISEASES: A REVIEW OF GUIDELINE RECOMMENDATIONS
Presenter: Jacob Hartz Boston Children’s Hospital
17:10
EXPLORING THE PROMISES OF CARDIAC REHABILITATION IN CHILDREN
Presenter: Michael Khoury
16:30 ‐ 17:30
Plenary
2019 CCS/CIHR‐ICRH DISTINGUISHED LECTURER AWARD IN CARDIOVASCULAR SCIENCES
PRIX DE CONFÉRENCIER ÉMÉRITE EN SCIENCES CARDIOVASCULAIRES SCC‐ISCR DES IRSC 2019
CIHR
520BE
Chair: Ryan Perry
Keynote Speaker: Rob Beanlands
Target Audience: General: All cardiovascular (clinical and research) health professionals
16:30 ‐ 17:30
Workshop
CANADIAN CARDIOVASCULAR SOCIETY ST‐ELEVATION MYOCARDIAL INFARCTION GUIDELINES: ARE WE COMPLIANT ACROSS CANADA? DO WE NEED TO DEVELOP AND REPORT NEW QUALITY INDICATORS BASED ON THESE GUIDELINES?
LES LIGNES DIRECTRICES DE LA SOCIÉTÉ CANADIENNE DE CARDIOLOGIE SUR L'INFARCTUS DU MYOCARDE AVEC ÉLÉVATION DU SEGMENT ST : QUEL EST LE NIVEAU DE CONFORMITÉ DANS L'ENSEMBLE DU PAYS? AVONS‐NOUS BESOIN D'ÉLABORER DE NOUVEAUX INDICATEURS DE QUALITÉ FONDÉS SUR
PLCY CAD ACS & AMI QUALITY
Last updated: October 7, 2019
27
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
517C
Faculty: Ata‐ur‐Rehman Quraishi Karin Humphries Robert Welsh Akshay Bagai Laurie Lambert
Target Audience: Academic cardiovascular health professionals and researchers Interventional cardiologists Critical care cardiologists and specialists
Learning Objectives At the end of this session participants will be able to:
discuss the quality of care for different patient populations in Canada;
discuss the challenges of quality indicator measurement for PCI and STEMI in Canada, and how to measure adherence to Canada's new STEMI guidelines; and
discuss important elements of a good quality indicator.
16:30 ‐ 17:30
Workshop
RISKY BUSINESS: SYNCOPE ASSESSMENT IN WORRISOME SITUATIONS
UNE SITUATION RISQUÉE : L'ÉVALUATION DE LA SYNCOPE DANS LES SITUATIONS PRÉOCCUPANTES
EP EDU
520AD
Faculty: Teresa Kus Juan Guzman Safia chatur Thomas Roston Venkatesh Thiruganasambandamoorthy Roopinder Sandhu Colette Seifer Satish Raj Robert Sheldon Hamid Banijamali
Target Audience: General: All cardiovascular (clinical and research) health professionals Trainee (clinical) Clinical cardiologists
Learning Objectives At the end of this session participants will be able to:
identify the main risks posed by syncope during pregnancy;
describe the burden of syncope in childhood and adolescence; and
apply a validated risk score for syncope in the emergency department.
16:30 ‐ 17:30
Workshop
TAKING ADVANTAGE OF MULTIMODALITY IMAGING IN DAILY CLINICAL PRACTICE
TIRER PARTI DE L'IMAGERIE À MODALITÉS MULTIPLES DANS LE CONTEXTE DE LA PRATIQUE CLINIQUE QUOTIDIENNE
IMAG EDU
520CF
Last updated: October 7, 2019
28
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Thursday, October 24, 2019
Faculty: Gillian Nesbitt Karima Addetia Matthias Friedrich Paaladinesh Thavendiranathan Kalie Kebed
Target Audience: Trainee (clinical) General: All cardiovascular (clinical and research) health professionals Clinical cardiologists
Learning Objectives At the end of this session participants will be able to:
diagnose and decide on the appropriate management strategy for cardiac amyloidosis with the help of multimodality imaging;
better assess patients with myocarditis using multimodality imaging; and
recognize findings on cardiac MRI pertaining to both cardiac amyloid and myocarditis.
16:30 ‐ 17:30
Workshop
THE TOP 5 ICU TRIALS OF 2019 FOR THE CLINICAL CARDIOLOGIST IN LESS THAN 5 MINUTES
LES CINQ PLUS GRANDS ESSAIS AUX SOINS INTENSIFS DE 2019 EN 5 MINUTES POUR LE CARDIOLOGUE CLINIQUE
CAD GEN CAD ACS & AMI
522
Faculty: Sean Van Diepen Christopher Overgaard Emilie P Belley‐Côté Mia Bertic Lior Bibas Barry Burstein Patrick Lawler Maude Peretz‐Larochelle Penelope Rampersad Janek Senaratne Louise Sun Jordan Webber
Target Audience: Critical care cardiologists and specialists Trainee (clinical) General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
evaluate whether the results of new practice changing general ICU studies can be applied to cardiovascular patient care;
integrate new ICU‐based research evidence into the care of critically ill CICU patients; and
identify the strength and limitations of studies of mechanical ventilation tidal volume targets, timing of CRRT initiation, anti‐psychotic use in delirium, resuscitation endpoints in critically ill patients and routine intra‐arrest intubation in patients with cardiac arrest.
Last updated: October 7, 2019
29
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
09:00 ‐ 10:00
Plenary
JOINT CPCA‐CPS SCIENTIFIC SESSION ‐ CANNABIS, DRUGS AND OTHER NASTY THINGS FOR THE YOUNG OF HEARTS
SÉANCE SCIENTIFIQUE CONJOINTE DE L'ACCP/SCP ‐ CANNABIS, DROGUES ET AUTRES PRODUITS NÉFASTES POUR LES JEUNES DE CŒUR
CONG CPCA
518C
Co‐Chairs:
Jennifer Russell
Charles Rohlicek
Target Audience: General: All cardiovascular (clinical and research) health professionals Trainee (clinical) Pediatric cardiologists
09:00
CANNABIS IN CHILDREN AND ADOLESCENTS – WHAT THE PEDIATRIC CARDIOLOGIST NEEDS TO KNOW
Presenter: Richard Bélanger Québec City, Québec
09:30
VENTRICULAR ARRHYTHMIAS AND RECREATIONAL DRUGS, CAFFEINE AND NICOTINE – IS IT SIMPLY SUBSTANCE ABUSE, OR IS THERE UNDERLING CHANNELOPATHY?
Presenter: Marie‐Hélène Gagnon Montréal, Québec
09:00 ‐ 10:00 (RE)SUSS IT OUT: RESUSCITATION SIMULATION
LES SECRETS DE LA RÉANIMATION : SIMULATION DE RÉANIMATION
TRAINEE GENERAL
524A
Faculty: Christopher Fordyce Vancourver, British Columbia Penelope Rampersad Cleveland, Ohio Cleveland Clinic Sean Van Diepen Edmonton, Alberta Nicolas Thibodeau‐Jarry Montréal, Québec
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
review ACLS guidelines;
develop an approach to the initial management of a critically ill patient; and
review relevant CCS guidelines (STEMI ‐ 2019, Heart Failure ‐ 2017, Cardiac Arrest ‐ 2016); and
understand common communication barriers when caring for a critically ill patient.
Last updated: October 7, 2019
30
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
09:00 ‐ 10:00 HEMODYNAMICS AND CATH ‐ FOCUS ON CORONARIES
HÉMODYNAMIQUE ET CATHÉTÉRISME ‐ TOUT SUR LES ÉLÉMENTS STRUCTURELS
TRAINEE CARDIOLOGY
524C
Faculty: Alexis Matteau Montréal, Québec Brian Potter Montréal, Québec
Target Audience: Trainee (clinical)
09:00 ‐ 10:00 RENAISSANCE OF THE CARDIOVASCULAR PHYSICAL EXAM
LE RETOUR DE L'EXAMEN PHYSIQUE CARDIOVASCULAIRE
TRAINEE GENERAL
524B
Faculty: Anita Chan Toronto, Ontario Véronique Cyr Montréal, Québec Nicolas Thibodeau‐Jarry Montréal, Québec Eric Yu Toronto, Ontario
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
review physical exam findings of common acute and chronic cardiovascular conditions; and
develop an approach to the diagnosis and initial management of cardiovascular diagnoses commonly seen on the wards/clinics.
09:00 ‐ 10:00
Guidelines
2019 CCS/CHRS POSITION STATEMENT ON THE MANAGEMENT OF VENTRICULAR TACHYCARDIA AND FIBRILLATION IN PATIENTS WITH STRUCTURAL HEART DISEASE
ÉNONCÉ DE POSITION DE 2019 DE LA SCC/SCR SUR LA PRISE EN CHARGE DE LA TACHYCARDIE VENTRICULAIRE ET DE LA FIBRILLATION VENTRICULAIRE CHEZ DES PATIENTS ATTEINTS D'UNE CARDIOPATHIE STRUCTURELLE
EP EDU CHRS
517C
Faculty: Eugene Crystal Jacqueline Joza Marc Deyell John Sapp
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
Last updated: October 7, 2019
31
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Learning Objectives At the end of this session participants will be able to:
understand the importance of a comprehensive initial investigation for patients with VT/VF and which diagnostic tests are appropriate;
initiate appropriate acute therapy for VT/VF;
understand the indications for initiating chronic suppressive therapy for VT/VF in structural heart disease;
understand the pharmacologic, intervention and device management of patients with VT/VF in structural heart disease;
recognize alternative therapies for patients with refractory VT/VF; and
recognize the psychosocial impacts of VT/VF.
09:00 ‐ 10:00
Plenary
WILFRED G. BIGELOW LECTURE & PAUL CARTIER AWARD
CONFÉRENCE WILFRED G. BIGELOW ET PRIX PAUL CARTIER
SURG CSCS
519A
Chair: Jean‐Francois Légaré
Target Audience: Cardiac surgeons
09:00
EVOLUTION OF AORTIC ROOT SURGERY OVER THE LAST 40 YEARS
Keynote Speaker: Magdi Yacoub London, United Kingdom
09:00 ‐ 10:00
Workshop
"CHIP"PING AWAY AT HF: A FRANK DISCUSSION ON FRAILTY, HFREF AND PROCEDURAL INTERVENTIONS
DÉMYSTIFIER L’INSUFFISANCE CARDIAQUE : UNE DISCUSSION FRANCHE SUR LA FRAGILITÉ, L’ICFER ET LES INTERVENTIONS PROCÉDURALES
HF CSI
517D
Faculty: Elizabeth Swiggum Rakesh Arora Harriette Van Spall Olga Toleva Hung Ly Najah Adreak David Bewick Shelley Zieroth Rodolfo Pike Vladimir Dzavik Kim Anderson
Target Audience: General: All cardiovascular (clinical and research) health professionals Trainee (clinical) Interventional cardiologists
Last updated: October 7, 2019
32
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Learning Objectives At the end of this session participants will be able to:
describe the clinical tools for assessing frailty in elderly patients and the options for and barriers to medical optimization of frail patients living with heart failure;
recognize the benefits of a Heart Team approach to decision making in older adult patients and those living with heart failure; and
describe clinical characteristics which are associated with favorable and unfavorable outcomes associated with CHIP and TAVI procedures in patients living with heart failure.
09:00 ‐ 10:00
Workshop
SHARED DECISION MAKING IS THE NEW PARADIGM TOWARDS SCREENING AND CARE OF THE ATHLETE: A CASE BASED TRANSLATION OF THE CCS/CHRS JOINT POSITION STATEMENT
LA PRISE DE DÉCISION PAR CONSENSUS EST LE NOUVEAU PARADIGME EN MATIÈRE DE DÉPISTAGE ET DE SOINS CHEZ L'ATHLÈTE : UNE APPLICATION AXÉE SUR LES CAS DE L'ÉNONCÉ DE POSITION SCC/SCR
PREV EDU
520BE
Faculty: Amer Johri Andrew Pipe Anne Fournier Taryn Taylor Paul Poirier François Philippon
Nicholas Grubic Margaret Robin Cases
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
translate the practice recommendations from the recently published CCS/CHRS Joint Position Statement on the cardiovascular screening of competitive athletes, allowing them to initiate a pre‐participation screening program (Cardiovascular Screening and Care of the Athlete Program) at their home institution;
identify 'Red Flags' associated with hypertrophic cardiomyopathy, arrhythmia, and coronary anomalies in athletes, as well as manage and monitor athletes with implantable cardioverter‐defibrillators, ensuring these athletes are safe in their participation in high‐intensity and/or endurance sport; and
utilize novel concepts and experimental work associated with the non‐binary shared‐decision making approach to athletic cardiovascular screening in a practical clinical setting, particularly relating to sports participation, restriction, and/or return‐to‐play decisions.
09:00 ‐ 10:00
Workshop
THE HIGHLY ACTIVE CARDIAC UNIT
Last updated: October 7, 2019
33
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
L'UNITÉ CARDIAQUE TRÈS ACTIVE
NURSING CAD ACS & AMI HF
520CF
Faculty: Michael Goldfarb Diana Dima Barry Burstein Julie Valiquette Joelle Berube‐Dufour
Target Audience: Cardiac technicians & nurses Critical care cardiologists and specialists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
describe the benefits and role of early mobilization in people with acute cardiac disease;
identify and address common barriers to early mobilization in acute cardiac patients; and
implement a nurse‐driven early mobilization program in their cardiac care unit.
09:00 ‐ 10:00
Workshop
WHEN SHOULD WE TAKE ADVANTAGE OF PERCUTANEOUS THERAPIES FOR VALVULAR HEART DISEASE IN OUR PATIENTS? FOCUS ON THE MITRAL AND TRICUSPID VALVES
QUAND DEVONS‐NOUS TIRER PARTI DES TRAITEMENTS PERCUTANÉS DES
VALVULOPATHIES CHEZ NOS PATIENTS? LES VALVES MITRALE ET ATRIOVENTRICULAIRE DROITE
IMAG HF
520AD
Faculty: Nicolo Piazza Gillian Nesbitt Wendy Tsang Karima Addetia Rebecca Hahn Kalie Kebed
Target Audience: Clinical cardiologists Echocardiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
select patients for mitraclip therapy;
select patients for percutaneous intervention on a prosthetic valve and predict whether an intervention will be successful; and
summarize the experience so far with percutaneous tricuspid therapies and identify the patients who may benefit.
09:00 – 12:00
Accredited Symposium
CUBED: CARDIOLOGISTS UNIFIED IN BUILDING EXCELLENCE IN DIABETES
CUBED : CARDIOLOGISTS UNIFIED IN BUILDING EXCELLENCE IN DIABETES (L'UNION DES CARDIOLOGUES POUR LA PROMOTION DE
Last updated: October 7, 2019
34
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
L'EXCELLENCE DES SOINS OFFERTS AUX PATIENTS DIABÉTIQUES)
VASC CAD GEN CSI ASO HF EDU CLINICAL CARDIOLOGY
516ABC
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was co‐developed with the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through educational grants from Astra Zeneca, Boehringer‐Ingelheim ‐ Eli Lilly Alliance, HLS Therapeutics Inc., Janssen, Merck Canada, Novartis, and Novo Nordisk.
Click here to view the program!
Co‐Chairs: Lawrence Leiter Subodh Verma
Facultys: Deepak Bhatt Michael Farkouh Ronald Goldenberg G.B. John Mancini Scott Solomon Jordan Weinstein
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
describe the cardio‐renal spectrum in type 2 diabetes (T2D);
differentiate between the cardiovascular outcome trials in T2D;
implement the recommendations of clinical practice guidelines and translate recent clinical trial evidence into risk‐reduction approaches in T2D; and
develop partnerships across the continuum of patient care to promote shared decision making for patients who have T2D.
09:00
OPENING REMARKS AND OBJECTIVES
Presenter: Lawrence Leiter
09:05
CVOTS WITH GLUCOSE‐LOWERING AGENTS: KEY TAKE AWAYS FOR CARDIOLOGISTS
Presenter: Lawrence Leiter
Learning Objectives At the end of this session participants will be able to:
to describe the rationale behind the CVOTs; and
to recall the study populations and results of the CVOTs that led to guideline change.
09:20
GLP‐1 RECEPTOR AGONISTS AND ATHEROSCLEROSIS: THE LATEST CLINICAL TRIAL EVIDENCE
Last updated: October 7, 2019
35
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Presenter: Michael Farkouh
Learning Objectives At the end of this session participants will be able to:
to compare the recent GLP‐1RA trial results with those already reported; and
to discuss how these new data may impact on clinical practice and patient choice.
09:35
THE CARDIORENAL INTERFACE OF DIABETES: CLINICAL TRIALS UPDATE
Presenter: Jordan Weinstein
Learning Objectives At the end of this session participants will be able to:
to outline how CV and renal function drive therapeutic decisions in diabetes; and
to summarize the renal outcomes of the CVOTs and a SGLT2 inhibitor renal outcome trial.
09:50
Q&A
10:00
HEALTH BREAK/MEET THE SPEAKERS
10:30
A NOVEL ROLE OF EPA IN DIABETES: CASTING ANOTHER LIGHT ON TRIGLYCERIDES
Presenter: Deepak Bhatt
Learning Objectives At the end of this session participants will be able to:
to recap the relationship between triglycerides and the risk for ASCVD;
to review the newest data on adjunct EPA therapy in diabetes.
10:35
DIABETES, SGLT2I AND HEART FAILURE: AN ESSENTIAL PRIMER
Presenter: Subodh Verma
Learning Objectives At the end of this session participants will be able to:
to recognize that HF is a clinically significant comorbidity in diabetes; and
to highlight the latest trial findings on SGLT2 inhibition in HF.
11:00
HFPEF IN DIABETES
Presenter: Scott Solomon
Learning Objectives At the end of this session participants will be able to:
to detail the different types of heart failure; and
to communicate the emerging trial data on novel HF therapies in diabetes.
11:15
INTEGRATING SCIENCE AND GUIDELINES INTO A PRACTICAL CALL TO ACTION FOR CARDIOVASCULAR SPECIALISTS: AN INTERACTIVE CASE‐BASED DISCUSSION
Last updated: October 7, 2019
36
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Presenters: G.B. John Mancini Ronald Goldenberg
Learning Objectives At the end of this session participants will be able to:
to interpret how the CVOT data may be translated to people with type 2 diabetes, with and without ASCVD;
to infer how the guidelines may change to accommodate the use of SGLT2 inhibitors beyond type 2 diabetes; and
to determine how to optimize lipid‐lowering strategies so as to lower residual risk in people with type 2 diabetes.
11:29
Q&A ‐ ALL FACULTY
11:40
CLOSING REMARKS
Presenter: Subodh Verma
09:00 ‐ 15:30 CANADIAN SOCIETY OF CARDIOLOGY TECHNOLOGISTS EDUCATION DAY
JOURNÉE DE FORMATION DE LA SOCIÉTÉ CANADIENNE DES TECHNOLOGUES EN CARDIOLOGIE
CSCT
522
Target Audience: Cardiac technologists
09:00
THE TRIPLE CROWN: INTEGRATING BEST PRACTICES IN 3D, STRAIN AND CONTRACT ECHOCARDIOGRAPHY
Presenter: Igal Sebag
10:00
COFFEE BREAK (in Community Forum)
10:30
PACEMAKERS, DEFIBRILLATORS, RESYNCHRONIZATION THERAPY: WHICH DEVICE FOR WHICH PATIENT?
Presenter: Colette Seifer
11:15
ADVANCEMENTS IN CARDIAC SURGERY: NEW AND EVOLVING ROLE OF CARDIAC SURGERY
Presenter: Jean‐Francois Légaré
12:00
LUNCH (in Community Forum)
14:00
PEDIATRIC CARDIOLOGY UPDATE
Presenter: Reeni Soni
14:45
ADVANCES IN INTERVENTIONAL CARDIOLOGY: CONQUERING NEW FRONTIERS
Presenter: Ali Abualsaud
15:30
Last updated: October 7, 2019
37
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
CCC RECEPTION (in Community Forum)
09:30 ‐ 16:30
Networking
CCC 2019 COMMUNITY FORUM OPEN
OUVERTURE DU FORUM COMMUNAUTAIRE DU CCSC 2019
NETWORKING
Community Forum, Level 200
10:00 ‐ 10:30 HEALTH BREAK, EPOSTER PRESENTATIONS, MODERATED PRESENTATIONS, COMMUNITY FORUM THEATRE AND EXHIBITION
PAUSE SANTÉ, PRÉSENTATIONS DES AFFICHES ÉLECTRONIQUES, PRÉSENTATIONS DIRIGÉES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
10:30 ‐ 11:30 (RE)SUSS IT OUT: RESUSCITATION SIMULATION
LES SECRETS DE LA RÉANIMATION : SIMULATION DE RÉANIMATION
TRAINEE GENERAL
524A
Faculty: Christopher Fordyce Vancourver, British Columbia Penelope Rampersad Cleveland, Ohio Cleveland Clinic Sean Van Diepen Edmonton, Alberta
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
review ACLS guidelines;
develop an approach to the initial management of a critically ill patient; and
review relevant CCS guidelines (STEMI ‐ 2019, Heart Failure ‐ 2017, Cardiac Arrest ‐ 2016); and
understand common communication barriers when caring for a critically ill patient.
10:30 ‐ 11:30 HEMODYNAMICS AND CATH ‐ FOCUS ON STRUCTURAL
HÉMODYNAMIQUE ET CATHÉTÉRISME ‐ TOUT SUR LES CORONAIRES
TRAINEE CARDIOLOGY
524C
Faculty: Anthony Main
Target Audience: Trainee (clinical)
10:30 ‐ 11:30 RENAISSANCE OF THE CARDIOVASCULAR PHYSICAL EXAM
LE RETOUR DE L'EXAMEN PHYSIQUE CARDIOVASCULAIRE
TRAINEE GENERAL
Last updated: October 7, 2019
38
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
524B
Faculty: Michael Froeschl Ottawa, Ontario Victoria Korley Toronto, Ontario Donald Palisaitis Montréal, Québec Varinder Randhawa Cleveland, Ohio
Target Audience: Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
review physical exam findings of common acute and chronic cardiovascular conditions; and
develop an approach to the diagnosis and initial management of cardiovascular diagnoses commonly seen on the wards/clinics.
10:30 ‐ 11:30
Workshop
MY WORST ARRHYTHMIA NIGHTMARE 2019 WORKSHOP
ATELIER MON PIRE CAUCHEMAR D’ARYTHMIE 2019
EP HF
520CF
Faculty: Laurent Macle Jason Andrade
John Sapp Bernard Thibault
Target Audience: Clinical cardiologists Trainee (clinical) Electrophysiologists
Learning Objectives At the end of this session participants will be able to:
evaluate and manage patients with non sustained ventricular tachycardia and newly diagnosed dilated cardiomyopathy with severe left ventricular dysfunction;
interpret the ECG of patients with conduction disturbances in the context of acute myocardial infarction and identify the need for pacing; and
evaluate patients with AV conduction disorders (limiting optimisation of medical treatment or requiring pacing), moderate LV dysfunction (LVEF 35‐40%) and narrow QRS.
10:30 ‐ 11:30
Workshop
MY WORST ECHO NIGHTMARE IV: CASES FROM COAST TO COAST
MON PIRE CAUCHEMAR D’ÉCHOGRAPHIE IV : DES CAS DES QUATRE COINS DU PAYS
IMAG CAD ACS & AMI
520AD
Faculty: Sabe De Jasmine Grewal Nowell Fine
Last updated: October 7, 2019
39
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Davinder Jassal Bibiana Cujec Igal Sebag David Bewick David McCarty Gillian Nesbitt Sarah Ramer Christine Henri Usha Manian Howard Leong‐Poi
Target Audience: Academic cardiovascular health professionals and researchers Trainee (clinical) General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
assess valvular abnormalities diagnosed on echocardiography and the acute management of such lesions in emergent settings;
recognize cardiovascular emergencies (tamponade, aortic dissection, thrombus) that require immediate diagnosis and clinical attention; and
describe recognized life threatening complications of myocardial infarction and appropriate diagnosis and interventions.
10:30 ‐ 12:00 CARDIOLOGY CARMS INFO SESSION WITH CARDIOLOGY RESIDENTS
SÉANCE D'INFORMATION SUR LE JUMELAGE CARMS EN CARDIOLOGIE À L'INTENTION DES RÉSIDENTS EN CARDIOLOGIE
TRAINEE CARDIOLOGY
Trainee Lounge, Community Forum
Faculty: Cynthia Allard Rachelle Krause Nikita Malhotra Hamilton, Ontario Michael Thibert Vancouver, British Columbia
Target Audience: Trainee (clinical)
10:30 ‐ 12:00
Plenary
CCS/ESC JOINT PLENARY: ALL COMPLEX CONGENITAL HEART DISEASE PATIENTS (SUCH AS FONTAN/ D‐TGV/ TOF) COULD UNDERGO A PREGNANCY
TOUTES LES PATIENTES ATTEINTES D’UNE CARDIOPATHIE CONGÉNITALE COMPLEXE (TELLES QUE FONTAN, D‐TRANSPOSITION DES GROS VAISSEAUX ET TÉTRALOGIE DE FALLOT) POURRAIENT AVOIR UNE GROSSESSE
CONG ESC
517C
Co‐Chairs: Chiara Bucciarelli‐Ducci Andrew Krahn
Debater ‐ Pro: Francois Marcotte
Debater ‐ Con: Gerhard Diller
Presenter: Line Leduc
Target Audience: Adult congenital cardiologists
Last updated: October 7, 2019
40
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
General: All cardiovascular (clinical and research) health professionals General practitioners
10:30 ‐ 12:00
Plenary
CPCA RICHARD ROWE AWARD COMPETITION
CONCOURS POUR LE PRIX RICHARD ROWE DE L'ACCP
CONG CPCA
518C
Co‐Chairs: Emilie Jean‐St‐Michel Andrew Mackie
Target Audience: Pediatric cardiologists
10:30 160 ROLE OF ETHNIC ORIGINS IN THE PROVINCE OF QUÉBEC FOR THE RISK OF DEVELOPPING KAWASAKI DISEASE Presenter: Emilie St‐Laurent Montréal, Québec 10:42 161 TRICUSPID VALVE PROLAPSE IN CHILDREN WITH HYPOPLASTIC LEFT HEART SYNDROME PATIENTS REQUIRING TRICUSPID VALVE REPAIR IS DUE TO LEAFLET MALADAPTATION, NOT SUB‐VALVE CHANGES ‐ A QUANTITATIVE THREE‐DIMENSIONAL ECHOCARDIOGRAPHY STUDY
Presenter: Sachie Shigemitsu Edmonton, Alberta 10:54 162 MISOPROSTOL ATTENUATES CARDIOMYOCYTE PROLIFERATION IN THE NEONATAL HEART THROUGH A BNIP3‐DELTA‐EXON3/MEF2‐DEPENDENT SIGNALLING PATHWAY Presenter: Matthew Martens Winnipeg, Manitoba 11:06 163 DIAGNOSIS AND OUTCOMES OF PATIENTS WITH SUPRAVALVULAR PULMONARY STENOSIS TREATED WITH PERCUTANEOUS BALLOON DILATION Presenter: Steffany Poupart St‐Sauveur, Québec 11:18 164 TRICUSPID VALVE (TV) LEAFLET EXPANSION IS THE MAIN ADAPTIVE CHANGE TO MAINTAIN COMPETENCY: A THREE‐DIMENSIONAL ECHOCARDIOGRAPHY (3DE) STUDY IN A NOVEL CHRONIC RIGHT VENTRICULAR (RV) PRESSURE AND VOLUME LOADED PIGLET MODEL Presenter: Lily Lin Edmonton, Alberta 11:30 165
Last updated: October 7, 2019
41
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
THE NORMAL AORTIC ROOT AND CUSP CONFIGURATION IN PEDIATRIC PATIENTS: GUIDE TO A SUCCESSFUL AORTIC VALVE REPAIR Presenter: Ismail Bouhout Montréal, Québec 11:42 DELIBERATION AND AWARD
For detailed abstract information, please refer to the CPCA section of the Final Programme or the CCC App.
10:30 ‐ 12:00
Workshop
CSCS POST‐GRAD COURSE
COURS POSTDOCTORAL DE LA SCCC
SURG CSCS TRAINEE
519A
Target Audience: Cardiac surgeons
10:30
CARDIAC SURGERY IN THE DEVOLPING WORLD
Presenter: Magdi Yacoub
10:55
AORTIC VALVE, IS IT STILL SURGICAL
Presenter: Raymond Cartier
11:15
SHOULD WE WIDEN OUR INTEREST IN THE TRICUSPI VALVE
Presenter: Richard Cook
11:35
MANAGING THE AORTIC ARCH DURING AORTIC DISSECTION
Presenter: Maral Ouzounian
10:30 ‐ 12:00
Workshop
A NEW PARADIGM FOR MEDICAL EDUCATION IN CANADA AND THE US: COMPETENCY BASED MEDICAL EDUCATION; CHALLENGES AND OPPORTUNITIES FROM BOTH SIDES OF THE BORDER
UN NOUVEAU PARADIGME EN MATIÈRE DE FORMATION MÉDICALE AU CANADA ET AUX ÉTATS‐UNIS : LA FORMATION MÉDICALE FONDÉE SUR LES COMPÉTENCES; LES DIFFICULTÉS ET LES POSSIBILITÉS À SAISIR DES DEUX CÔTÉS DE LA FRONTIÈRE
EDU
520BE
Faculty: Nicolas Thibodeau‐Jarry Jean‐Bernard Breau Julie Damp Alison Montgomery Fraser Rubens Marty Tam Andrew Warren Gaby Weissman
Last updated: October 7, 2019
42
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Target Audience: General: All cardiovascular (clinical and research) health professionals Pediatric cardiologists Cardiac surgeons
Learning Objectives At the end of this session participants will be able to:
differentiate competency based medical education from traditional time‐based medical education and list the challenges and opportunities offered by this new paradigm for cardiovascular training in Canada and in the United States;
compare and contrast different approaches to the implementation of competency based medical education in cardiovascular training, namely the ACGME's milestones and the ACC's COCATS in the United States and the Royal College of Canada's competency by design approach; and
list different tools that will be important in the new paradigm of competency based medical education, namely simulation and giving timely and pertinent feedback.
10:30 ‐ 12:00
Workshop
CANADIAN HEART FAILURE SOCIETY SPOTLIGHT: CARDIO‐ONCOLOGY: DEBUNKING MYTHS ‐ DOES SURVIVING CANCER MEAN LIVING WITH HEART FAILURE?
LA SOCIÉTÉ CANADIENNE D’INSUFFISANCE CARDIAQUE EN VEDETTE : CARDIO‐ONCOLOGIE : DÉMYSTIFIONS LES MYTHES ‐ SURVIVRE AU CANCER IMPLIQUE‐T‐IL NÉCESSAIREMENT L’INSUFFISANCE CARDIAQUE?
HF CHFS IMAG
517D
Faculty: Shelley Zieroth Anique Ducharme James White Brian Clarke Elizabeth Swiggum Paaladinesh Thavendiranathan Francois Tournoux Jennifer Amadio Nathaniel Hawkins John MacFadyen
Target Audience: Clinical cardiologists Heart failure specialists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
describe the journey of a patient who survived cancer and the exposures that may increase their risk of heart failure;
describe contemporary strategies for the prevention and early diagnosis of cardiotoxicity in cancer patients; and
describe the investigation, prognosis and management of oncology patients developing heart failure.
12:00 ‐ 14:00 LUNCH BREAK, EPOSTER VIEWING, COMMUNITY FORUM THEATRE AND EXHIBITION
Last updated: October 7, 2019
43
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
PAUSE DÎNER, VISIONNEMENT DES AFFICHES ÉLECTRONIQUES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
12:30 ‐ 13:30
Accredited Symposium
ACUTE CORONARY SYNDROMES AND LIPID MANAGEMENT 2020: THE DECADE AHEAD
SYNDROMES CORONARIENS AIGUS ET PRISE EN CHARGE DES LIPIDES 2020 : LA PROCHAINE DÉCENNIE
CAD ACS & AMI EDU CLINICAL CARDIOLOGY
517D
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was developed by the Canadian Collaborative Research Network and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through an educational grant from Sanofi.
Click here to view the program!
Planning Committee Members: David Bewick Shaun Goodman
Chair: Milan Gupta
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
define a guideline‐centric approach to lipid management in post‐ACS patients; and
define a guideline‐centric approach to lipid management in post‐ACS patients.
12:30
Welcome
Presenter: Milan Gupta
12:35
Case Presentation and Interactive Questions
Presenter: Shaun Goodman
Learning Objectives At the end of this session participants will be able to:
define challenges for ACS patients transitioning from hospital to ambulatory specialty care.
12:45
What Defines Optimal Lipid Therapy following acute coronary syndromes
Presenter: Deepak Bhatt
Learning Objectives At the end of this session participants will be able to:
Last updated: October 7, 2019
44
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
identify optimal strategies for reducing CV risk attributable to lipids in ACS patients.
13:05
Rapid‐fire interactive discussion round
Presenters: Deepak Bhatt Shaun Goodman Milan Gupta
13:30
Session Close
Presenter: Milan Gupta
12:30 ‐ 13:30
Accredited Symposium
THE HF QUEST: DECODING THE EVIDENCE TO TRANSFORM HEART FAILURE OUTCOMES
LA RECHERCHE EN IC : DÉCRYPTER LES DONNÉES PROBANTES POUR TRANSFORMER LES RÉSULTATS DANS LE DOMAINE DE L'INSUFFISANCE CARDIAQUE
HF EDU CLINICAL CARDIOLOGY
517C
This event is an Accredited Self‐Assessment Program under Section 3 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was co‐developed with the Canadian Cardiovascular Society and Novartis Pharma Canada Inc. and was planned to achieve scientific integrity, objectivity and balance. This
program was made possible through an educational grant from Novartis Pharma Canada Inc.
Click here to view the program!
Co‐Chairs: Abhinav Sharma Shelley Zieroth
Planning Committee Members: Anil Gupta Heather Ross Scott Solomon
Target Audience: General: All cardiovascular (clinical and research) health professionals Heart failure specialists Learning Objectives At the end of this session participants will be able to:
discuss the outcomes of recent late‐breaking heart failure trials, including PARAGON;
implement practical recommendations for timely identification and management of acute decompensated heart failure; and
recognize the importance of optimizing heart failure treatment in the acute hospital setting.
12:30
WELCOME AND INTRODUCTION
Presenter: Shelley Zieroth
12:35
HFPEF CASE PRESENTATION
Last updated: October 7, 2019
45
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Presenters: Abhinav Sharma Shelley Zieroth
12:40
HFPEF AND PARAGON CLINICAL EVIDENCE
Presenter: Scott Solomon
Learning Objectives At the end of this session participants will be able to:
review the diagnostic strategies for patients for HFpEF;
highlight the results of the PARAGON trial; and
discuss the real‐world implications of these results.
12:55
ENIGMA QUESTIONS – INTERACTIVE AUDIENCE POLLING
Presenter: Shelley Zieroth
13:00
HFREF CASE PRESENTATION
Presenters: Abhinav Sharma Shelley Zieroth
13:05
HFREF AND IN‐HOSPITAL INITITATION: CLINICAL EVIDENCE
Presenter: Heather Ross
Learning Objectives At the end of this session participants will be able to:
review the epidemiology of GDMT in the hospital setting and its impact on outcomes;
discuss contemporary data on the initiation of HF therapies during hospitalization; and
understand gaps in knowledge for patients transitioning from in patient to the ambulatory setting.
13:20
ENIGMA QUESTIONS – INTERACTIVE AUDIENCE POLLING
Presenter: Shelley Zieroth
13:25
ENIGMA WRAP‐UP
Presenter: Shelley Zieroth
14:00 ‐ 15:00 LVAD PARAMETERS
PARAMÈTRES DES DAVG
TRAINEE SURGICAL
524B
Faculty: Najah Adreak Dave Nagpal London, Ontario Varinder Randhawa Cleveland, Ohio
Last updated: October 7, 2019
46
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Mustafa Toma Vancouver, British Columbia
Target Audience: Cardiac surgery residents only
14:00 ‐ 15:00 MANAGING FINANCES FOR THE YOUNG PROFESSIONAL
COMMENT GÉRER SES FINANCES EN TANT QUE JEUNE PROFESSIONNEL
TRAINEE GENERAL
Trainee Lounge, Community Forum
Faculty: Dominic Boisvert
Target Audience: Trainee (clinical) Trainee (research)
14:00 ‐ 15:00 PUBLISH OR PERISH: TIPS FOR SUCCESS
PUBLIER OU PÉRIR : DES CONSEILS DE RÉUSSITE
TRAINEE RESEARCH
524C
Faculty: Jaffer Iqbal Emilie P Belley‐Côté Hamilton, Ontario William McIntyre Hamilton, Ontario Stanley Nattel Montréal, Québec Caren Solomon Boston, Massachusetts New England Journal of Medicine
Target Audience: Trainee (research)
14:00 ‐ 15:00
Workshop
A SESSION FOR ECG LOVERS
UNE SÉANCE POUR LES AMATEURS D'ECG
EP EDU
520CF
Faculty: Adrian Baranchuk George Veenhuyzen Peter Guerra Martin Green
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
to recognize supraventricular tachycardias, WPW ECG pattern and Wenckebach phenomenon;
identify the most common ECG presentations of Lyme carditis; and
to determine when Wenckebach phenomenon requires treatment, when WPW ECG pattern requires invasive management and when Lyme carditis requires pacing.
14:00 ‐ 15:30
Last updated: October 7, 2019
47
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
CSCS BEST ABSTRACTS ORAL SESSION I
SÉANCE DES MEILLEURS RÉSUMÉS DE LA SCCC I
SURG CSCS
519A
Target Audience: Cardiac surgeons Cardiac surgery residents 14:00 146 RECELLULARIZATION OF ACELLULAR XENOGENIC SCAFFOLD WITH AUTOLOGOUS HUMAN MESENCHYMAL STEM CELLS RESCUES THE XENOREACTIVE IMMUNE RESPONSE Presenter: Sabin Bozso 14:15 147 PARADOXICAL LOW‐FLOW AORTIC STENOSIS: SHOULD WE WAIT FOR THE GRADIENT TO REACH 40 MMHG? Presenter: Ezequiel Guzzetti 14:30 148 LONG‐TERM INCIDENCE, SEVERITY AND IMPACT OF BLEEDING EVENTS AND QUALITY OF LIFE AFTER MECHANICAL AORTIC VALVE REPLACEMENT IN NON‐ELDERLY ADULTS Presenter: Marc‐Olivier Joly‐Comtois 14:45 149
OUTCOMES SUTURELESS AORTIC VALVE REPLACEMENT VERSUS CONVENTIONAL AORTIC VALVE REPLACEMENT AND TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META‐ANALYSIS Presenter: Ahmed Makhdoum 15:00 150 A SURVEY OF CARDIAC SURGEONS TO EVALUATE THE USE OF SUTURELESS AORTIC VALVE REPLACEMENT IN CANADA Presenter: Ahmed Makhdoum 15:15 151 CADAVERIC ECMO CANNULATION SIMULATOR Presenter: Andrew Fagan
14:00 ‐ 15:30
Plenary
CCS/ACC JOINT PLENARY: THE CANADA VS. USA DEBATE SERIES
PLÉNIÈRE CONJOINTE SCC/ACC : LA SÉRIE DE DÉBATS CANADA‐ ÉTATS‐UNIS
HF EP SURG CSI ACC
517D
Last updated: October 7, 2019
48
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Co‐Chairs: Marc Ruel Mary Walsh
14:00
DEBATE: PATIENTS WITH CONGESTIVE HEART FAILURE WITH REDUCED EJECTION FRACTION SHOULD ROUTINELY BE REFERRED FOR ATRIAL FIBRILLATION ABLATION, YES OR NO?
Presenters: Mary Walsh Indianapolis, IN Jason Andrade Vancouver, British Columbia
Target Audience: General: All cardiovascular (clinical and research) health professionals Heart failure specialists Electrophysiologists
14:45
DEBATE: TAVI VS. SURGERY
Presenters: Anita Asgar Montréal, Québec Alistair Phillips
Target Audience: General: All cardiovascular (clinical and research) health professionals Cardiac surgeons Interventional cardiologists
14:00 ‐ 15:30
Plenary
HEART & STROKE PLENARY: SHIFTING THE RESEARCH TO ACTION PARADIGM: THE
COMPLEX CONNECTIONS AMONG CARDIOVASCULAR DISEASE, STROKE AND VASCULAR COGNITIVE IMPAIRMENT
PLÉNIÈRE DE COEUR + AVC : LE CHANGEMENT DE PARADIGME LORSQU'IL S'AGIT DE TRANSPOSER LA RECHERCHE EN ACTION : LES LIENS COMPLEXES ENTRE LES MALADIES CARDIOVASCULAIRES, L'AVC ET LES DÉFICITS COGNITIFS D'ORIGINE VASCULAIRE
VASC HSF
520BE
Faculty: Mary Elizabeth Harriman Patrice Lindsay Cindy Yip Sudi Barre Jillianne Code Heather Foulds Laura Gioia Andrew Krahn
Target Audience: General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
describe the connections among cardiovascular disease, stroke and vascular cognitive impairment, with a focus on the associated risk between cardiovascular disease vascular cognitive impairment;
appraise models to transform the way we can study these connections to drive changes in care, with consideration to unique challenges faced by Women and Indigenous people; and
Last updated: October 7, 2019
49
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
employ new approaches to drive change and improve prevention, diagnosis, disease management and recovery among people in Canada at risk or living with multiple conditions.
14:00 ‐ 15:30
Workshop
CANADIAN CARDIAC TRANSPLANT NETWORK SPOTLIGHT: WHEN PEDIATRIC SUCCESS LEADS TO ADULT FAILURE: ADVANCED HEART FAILURE THERAPIES IN ADULT CONGENITAL HEART DISEASE
SÉANCE VEDETTE DU RÉSEAU CANADIEN DE TRANSPLANTATION CARDIAQUE : QUAND LE SUCCÈS CHEZ L’ENFANT ENTRAÎNE L’ÉCHEC CHEZ L’ADULTE : TRAITEMENT DE L’INSUFFISANCE CARDIAQUE À UN STADE AVANCÉE EN CARDIOPATHIES CONGÉNITALES CHEZ L’ADULTE
HF CCTN CONG
517C
Faculty: Brian Clarke Kim Anderson Jasmine Grewal Anique Ducharme Adrienne Kovacs David Horne Shelley Zieroth Michael McDonald
Target Audience: General: All cardiovascular (clinical and research) health professionals Adult congenital cardiologists Cardiac transplant specialists
Learning Objectives At the end of this session participants will be able to:
review the common congenital heart diseases that can lead to heart failure;
recognize when to refer for advanced heart failure therapy and define the unique MCS and transplant issues in the ACHD population; and
define common psycho‐social challenges adult congenital heart disease patients face.
14:00 ‐ 15:30
Workshop
CANADIAN SOCIETY OF CARDIOVASCULAR NUCLEAR AND CT IMAGING SPOTLIGHT: NEW FRONTIERS IN CARDIAC IMAGING FOR HEART FAILURE
SÉANCE VEDETTE DE LA SOCIÉTÉ CANADIENNE DE CARDIOLOGIE NUCLÉAIRE ET DE TOMODENSITOMÉTRIE : NOUVELLES FRONTIÈRES EN IMAGERIE CARDIAQUE POUR L'INSUFFISANCE CARDIAQUE
IMAG CNCT HF
520AD
Faculty: Lisa Mielniczuk Gary Small Rob Beanlands Benjamin Chow
Target Audience: General: All cardiovascular (clinical and research) health professionals Trainee (clinical) Nuclear and CT imaging specialist
Last updated: October 7, 2019
50
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
Learning Objectives At the end of this session participants will be able to:
identify what advanced imaging has recently discovered about the modern heart failure patient;
recognize the importance of advance imaging findings in the diagnosis and prognosis of heart failure patients; and
apply advanced imaging techniques appropriately in the diagnosis and management of heart failure patients.
14:15 ‐ 15:30
Plenary
26TH ANNUAL TERRY KAVANAGH AWARD & LECTURE
26E PRIX ANNUEL ET CONFÉRENCE TERRY KAVANAGH
CACPR PREV
516ABC
15:30 ‐ 16:30 TRAINEE RESEARCH AWARD ‐ BASIC
CONG HF VASC SURG
Moderated Presentation Theatre A
15:30
EX SITU HEART PERFUSION IMPROVES PRESERVATION OF ENDOTHELIAL FUNCTION IN BOTH DBD AND DCD HEARTS
Presenter: Roberto Ribeiro
15:40
HEART‐FOCUSED IONIZING RADIATION INDUCED DNA DAMAGE ACTIVATES INFLAMMATION VIA CGAS‐STING PATHWAY LEADING TO CARDIAC REMODELING AND HEART FAILURE
Presenter: Mohammad Al‐Khalaf
15:50
MISOPROSTOL ATTENUATES CARDIOMYOCYTE PROLIFERATION IN THE NEONATAL HEART THROUGH A BNIP3‐DELTA‐EXON3/MEF2‐DEPENDENT SIGNALLING PATHWAY
Presenter: Matthew Martens
16:00
RECELLULARIZATION OF ACELLULAR XENOGENIC SCAFFOLD WITH AUTOLOGOUS HUMAN MESENCHYMAL STEM CELLS RESCUES THE XENOREACTIVE IMMUNE RESPONSE
Presenter: Sabin Bozso
16:10
A NOVEL ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (ARVC) BIOMARKER ANTI‐DSG2 IS ABSENT IN ATHLETES WITH RIGHT VENTRICULAR ENLARGEMENT
Presenter: David Dorian
Last updated: October 7, 2019
51
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
16:20
LARGE‐SCALE ASSESSMENT OF PLATELET DIFFERENTIAL SECRETION
Presenter: Samuel Fleury
15:30 ‐ 16:30 TRAINEE RESEARCH AWARD ‐ CLINICAL
IMAG HTN PLCY VASCULAR PREV EP
Moderated Presentation Theatre B
15:30
A CANADIAN COST‐EFFECTIVENESS ANALYSIS OF TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN LOW SURGICAL RISK PATIENTS
Presenter: Derrick Tam
15:40
MEASURES OF AORTIC STIFFNESS, CENTRAL BLOOD PRESSURE AND PULSATILE ARTERIAL LOAD PREDICT FUTURE ANEURYSM EXPANSION
Presenter: Kevin Boczar
15:50
MACHINE LEARNING TO FACILITATE ASSESSMENT OF DIASTOLIC FUNCTION BY ECHOCARDIOGRAPHY
Presenter: River Jiang
16:00
HLA‐G 14BP POLYMORPHISM DONOR/RECIPIENT MATCHING PROTECTS AGAINST DEVELOPMENT OF POST‐TRANSPLANT MALIGNANCY FOLLOWING HEART TRANSPLANTATION
Presenter: Mitchell Adamson
16:10
RARE LOSS‐OF‐FUNCTION VARIANT ANALYSIS IN LONE ATRIAL FIBRILLATION
Presenter: Julieta Lazarte
16:20
BENEFITS OF SLEEP APNEA SCREENING FOR RAPID ASSESSMENT AND MANAGEMENT OF DISEASE PROCESSES IN CARDIOVASCULAR PATIENTS
Presenter: Andrew Victor
15:30 ‐ 16:30 EPOSTER RECEPTION, EPOSTER PRESENTATIONS, MODERATED PRESENTATIONS, COMMUNITY FORUM THEATRE AND EXHIBITION
RÉCEPTION DES AFFICHES ÉLECTRONIQUES, PRÉSENTATIONS DES AFFICHES ÉLECTRONIQUES, PRÉSENTATIONS DIRIGÉES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
Last updated: October 7, 2019
52
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
16:30 ‐ 17:30
Guidelines
CCS POSITION STATEMENT ON POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
ÉNONCÉ DE POSITION DE LA SCC SUR LE SYNDROME DE TACHYCARDIE ORTHOSTATIQUE POSTURALE
EP EDU
520AD
Faculty: Satish Raj Juan Guzman Colette Seifer Paula Harvey Robert Sheldon Lawrence Richer
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners Learning Objectives At the end of this session participants will be able to:
review how to recognize POTS and disorders of orthostatic intolerance that are not POTS;
identify next steps in the diagnostic evaluation of POTS; and
examine the latest evidence regarding non‐pharmacological and pharmacological management strategies for POTS.
16:30 ‐ 17:30
Plenary
CARDIOVATION GAME SHOW WITH HOST ANSAR HASSAN
LE JEU‐QUESTIONNAIRE CARDIOVATION, PRÉSENTÉ PAR ANSAR HASSAN
220CDE ‐ Plenary Room via CF
Chair: Ansar Hassan
Dragons: Saurabh Gupta Chow Chi‐Ming Catherine Kells
Target Audience: General: All cardiovascular (clinical and research) health professionals
16:30 ‐ 17:30
Plenary
CCTN/CHFS RESEARCH COMPETITION
CONCOURS EN RECHERCHE RCTC/SCIC
CCTN HF CHFS
520BE
Target Audience: Cardiac transplant specialists Heart failure specialists
16:30 ‐ 17:30
Plenary
CPCA/CACH JOINT SYMPOSIUM II ‐ TRANSITION TO ADULT CARE IN CONGENITAL HEART DISEASES ‐ CANADIAN AND EUROPEAN INITIATIVES
SYMPOSIUM CONJOINT DE L'ACCP ET DU RCCCA II – LA TRANSITION VERS LES SOINS
Last updated: October 7, 2019
53
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
AUX ADULTES POUR LES CARDIOPATHIES CONGÉNITALES, LES INITIATIVES CANADIENNES ET EUROPÉENNES
CONG CPCA CACH
518C
Co‐Chairs: Tim Bradley Michelle Keir
Target Audience: Adult congenital cardiologists Pediatric cardiologists
16:30
EUROPEAN INITIATIVES IN TRANSITION TO ADULT CHD CARE
Presenter: Philip Moons
16:50
THE “PATIENT ADVISOR” PROJECT
Presenter: Janine Badr
17:10
THE CHAPTER STUDIES
Presenter: Andrew Mackie Edmonton, Alberta
16:30 ‐ 17:30
Plenary
YOUTH CARDIAC REHABILITATION
LA RÉADAPTATION CARDIAQUE CHEZ LES JEUNES
CACPR PREV
516ABC
16:30 ‐ 17:30
Plenary
CNCT DR. ROBERT J. BURNS MEMORIAL LECTURE
CONFÉRENCE COMMÉMORATIVE DR ROBERT J. BURNS DE LA SCCNT
IMAG
525
Faculty: Gary Small
Target Audience: Nuclear and CT imaging specialist
16:30 ‐ 17:30
Workshop
HOW TO TEACH CARDIAC SURGERY
COMMENT ENSEIGNER LA CHIRURGIE CARDIAQUE
SURG EDU
519A
Target Audience: Cardiac surgeons Cardiac surgery residents
16:30
TEACHING THE PGY 1‐2
Presenter: David Horne
Last updated: October 7, 2019
54
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Friday, October 25, 2019
16:45
TEACHING THE PGY‐4
Presenter: Michel Pellerin
17:00
TEACHING THE TRANSITION TO PRACTICE
Presenter: Michael Moon
16:30 ‐ 17:30
Workshop
CARDIOMYOPATHIE PÉRIPARTUM ET ARYTHMIE DURANT LA GROSSESSE
CARDIOMYOPATHIE PÉRIPARTUM ET ARYTHMIE DURANT LA GROSSESSE
HF CONG
517D
Faculty: Laurence Descarries Annie Dore Élisabeth Codsi Blandine Mondesert Hélène Mayrand Josée Morin Vicky Soulière Richard Essiambre Benoit Daneault Igal Sebag Isabelle Nault Catherine Bourque Benoit M‐Labbé
Target Audience: Clinical cardiologists Adult congenital cardiologists Electrophysiologists
Learning Objectives At the end of this session participants will be able to:
poser un diagnostic de cardiomyopathies péripartum;
proposer la thérapie appropriée en reconnaissant les facteurs de mauvais pronostic; and
reconnaitre les particularités du traitement des arythmies durant la grossesse chez les patientes avec ou sans cardiopathie.
Last updated: October 7, 2019
55
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
07:00 ‐ 10:00
Accredited Symposium
B2K19: NEW CONCEPTS SYMPOSIUM
B2K19 : SYMPOSIUM DES NOUVEAUX CONCEPTS
EP CAD ACS & AMI HF CSI EDU CLINICAL CARDIOLOGY
220CDE ‐ Plenary Room via CF
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was developed by the Canadian VIGOUR Centre and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through educational grants from AstraZeneca Canada Inc., Bayer Inc., BMS/Pfizer Alliance, Boehringer‐Ingelheim Eli Lilly Alliance, Novartis Pharmaceuticals Canada Inc., and Sanofi Canada.
Click here to view the program!
Co‐Chairs: Justin Ezekowitz Shaun Goodman
Planning Committee Members: David Bewick Heather Ross Robert Welsh Justin Ezekowitz Shaun Goodman
Target Audience: General: All cardiovascular (clinical and research) health professionals
Academic cardiovascular health professionals and researchers Heart Failure specialists. Learning Objectives At the end of this session participants will be able to:
review and discuss key diagnostic and therapeutic strategies to enhance the care of Canadian patients with stable and acute coronary artery disease, atrial fibrillation, heart failure, and diabetes mellitus.
07:00
WELCOME AND INTRODUCTION, PART I: NEW CONCEPTS IN ACUTE CORONARY SYNDROMES AND ATRIAL FIBRILLATION
Presenter: Shaun Goodman
07:00
PAUL W. ARMSTRONG B2K KEYNOTE PRESENTATION: CCS/CAIC GUIDELINES ON ACUTE MANAGEMENT OF STEMI
Presenter: Warren Cantor
Learning Objectives At the end of this session participants will be able to:
review the Canadian Cardiovascular Society (CCS)/Canadian Association of Interventional Cardiology (CAIC) Guideline recommendations on the acute management of ST‐segment elevation myocardial infarction (STEMI).
07:15
ANTITHROMBOTIC THERAPY IN AF AND ACS WITH AND WITHOUT PCI
Last updated: October 7, 2019
56
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Presenter: Jean‐Francois Tanguay
Learning Objectives At the end of this session participants will be able to:
examine the role for oral antithrombotic (antiplatelet and anticoagulant) therapy for secondary prevention in patients with an acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) with atrial fibrillation (AF).
07:29
LIPID‐LOWERING IN POST‐ACS PATIENTS
Presenter: Shaun Goodman
Learning Objectives At the end of this session participants will be able to:
examine the role for lipid lowering and dual antiplatelet therapy for secondary prevention in post‐ACS patients.
07:43
ANTITHROMBOTIC THERAPY BEYOND 1 YEAR POST‐ACS
Presenter: Robert Welsh
Learning Objectives At the end of this session participants will be able to:
examine the role for oral antithrombotic (antiplatelet and anticoagulant) therapy for secondary prevention in patients with chronic atherosclerotic cardiovascular disease (ASCVD).
07:57
CASE PRESENTATIONS
Presenter: Maude Peretz‐Larochelle
Learning Objectives At the end of this session participants will be able to:
integrate the abovementioned objectives in the context of a case‐based discussion regarding the diagnosis and management of ACS patients, including those with AF, and the longer‐term use of secondary prevention therapies in ASCVD patients.
08:22
NUTRITION BREAK
08:29
INTRODUCTION, PART II: NEW CONCEPTS IN HEART FAILURE AND DIABETES
Presenter: Justin Ezekowitz
08:30
DIABETES FOR THE CARDIOVASCULAR CLINICIAN
Presenter: Kim Connelly
Learning Objectives At the end of this session participants will be able to:
examine the role of new therapeutic agents for heart failure (HF), diabetes and the intersection of these two disease epidemics.
08:45
Last updated: October 7, 2019
57
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
IN‐HOSPITAL INITIATION OF HF THERAPIES: SWITCHING, SLOWING AND STAGNATION IN PRACTICE
Presenter: G. Michael Felker
Learning Objectives At the end of this session participants will be able to:
explore the selection and timing of advanced therapies to add to traditional pharmacologic and non‐pharmacologic therapies.
09:05
HOW TO RECOVER A VERY DILATED LEFT VENTRICLE WHEN MEDICAL THERAPY HAS FAILED
Presenter: Anita Asgar
Learning Objectives At the end of this session participants will be able to:
understand the role of emerging and established therapies in different populations of patients with heart failure.
09:19
HF WITH PRESERVED EJECTION FRACTION: NEW DIAGNOSTICS, NEW THERAPIES?
Presenter: Eileen O'Meara
Learning Objectives At the end of this session participants will be able to:
examine the role of new therapeutic agents for heart failure (HFpEF);
review currently available diagnostic tools and scores.
09:33
CASE PRESENTATIONS
Presenter: Kim Anderson
Learning Objectives At the end of this session participants will be able to:
integrate the above mentioned objectives in the context of a case‐based discussion regarding the management of patients with diabetes, and the diagnosis and management of HF patients.
10:00
CLOSING REMARKS
09:00 ‐ 09:45
Plenary
JOHN KEITH LECTURE
CONFÉRENCE JOHN KEITH
CONG CPCA
518C
Chair: Anne Fournier
Target Audience: Pediatric cardiologists Adult congenital cardiologists
09:00
STANDING ON THE SHOULDERS OF GIANTS: THE JOURNEY FROM INFANT SURVIVAL TO LONGEVITY IN CONGENITAL HEART DISEASE
Last updated: October 7, 2019
58
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Keynote Speaker: Philip Moons Leuven, Belgium
09:00 ‐ 10:00 CACPR PODIUM PRESENTATIONS: YOUTH CARDIAC REHABILITATION
PRÉSENTATIONS DE L'ACPRC : LA RÉADAPTATION CARDIAQUE CHEZ LES JEUNES
CACPR PREV
522
09:00
CARDIAC REHABILITATION FOR PEDIATRIC CONGENITAL HEART DISEASE
Presenters: Charissa Pockett Corey Tomczak
09:00 ‐ 10:00 ESTABLISHING YOUR CAREER IN CARDIAC SURGERY
LANCER SA CARRIÈRE EN CHIRURGIE CARDIAQUE
TRAINEE SURGICAL
524B
Faculty: Richard Cook Vancouver, British Columbia Marc Ruel Ottawa, Ontario
Target Audience: Cardiac surgery residents
09:00 ‐ 10:00 MULTIMODALITY IMAGING
L'IMAGERIE MULTIMODALE
TRAINEE CARDIOLOGY
524C
Faculty: Jonathan Afilalo Montréal, Québec Christine Henri Montréal, Québec Howard Leong‐Poi Toronto, Ontario
Target Audience: Trainee (clinical) Trainee (research)
09:00 ‐ 10:00 PACEMAKER/ICD SESSION: BEGINNER
SÉANCE STIMULATEURS CARDIAQUES/DÉFIBRILLATEURS IMPLANTABLES : NIVEAU DÉBUTANT
TRAINEE CARDIOLOGY
524A
Faculty: Jean‐Marc Raymond Montréal, Québec
Target Audience: Trainee (clinical) Trainee (research)
09:00 ‐ 10:00 Guidelines CURRENT ISSUES IN DYSLIPIDEMIA MANAGEMENT ENJEUX ACTUELS DE LA PRISE EN CHARGE DES DYSLIPIDÉMIES
Last updated: October 7, 2019
59
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
ASO EDU HTN PREV GUIDELINES
520CF Faculty: Glen Pearson George Thanassoulis Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners Learning Objectives At the end of this session participants will be able to:
identify the benefits of traditional risk models and added value of using vascular age and other approaches for identifying selected patients for earlier dyslipidemia treatment;
recognize the potential role of triglyceride‐rich lipoproteins and/or lipoprotein(a) in improving risk assessment for select patients; and
discuss the evidence for various lipid/lipoprotein thresholds for intensification of therapy, based on recent clinical trials.
09:00 ‐ 10:00
Workshop
CONTROVERSIES IN THE SURGICAL TIMING OF PATIENTS IN THE CORONARY INTENSIVE CARE UNIT: A CANCARE AND CSCS MINI‐DEBATE SESSION
DÉBATS EN MATIÈRE D'ÉTABLISSEMENT DU CALENDRIER DES INTERVENTIONS CHEZ LES PATIENTS DE L'UNITÉ DES SOINS INTENSIFS CORONARIENS : UNE SÉANCE DE MINI‐DÉBAT SCSIC ET SCCC
SURG CAD GEN
519A
Chair: Sean Van Diepen
Co‐Chair: Gregory Schnell
Target Audience: Critical care cardiologists and specialists Cardiac surgeons Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
critically appraise the data supporting early or delayed surgery in patients with endocarditis complicated by stroke;
identify which patients with mechanical complications following STEMI can undergo non‐emergent surgical intervention; and
critically appraise the evidence underpinning, and the clinical performance of, CCS wait‐list guidelines.
WELCOME AND INTRODUCTION Sean Van Diepen
PRE‐CABG DUAL ANTI‐PLATELET MANAGEMENT
Debaters: Craig Ainsworth Maral Ouzounian
Last updated: October 7, 2019
60
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
THE EFFECTIVENESS OF CURRENT CCS CARDIAC SURGERY WAIT‐LIST GUIDELINES
Debaters: Todd Anderson Michelle Graham
THE OPTIMAL TIMING OF CARDIAC SURGERY FOR PATIENT WITH A MECHANICAL COMPLICATION FROM STEMI WHO ARE NOT HEMODYNAMICALLY UNSTABLE
Debaters: Rakesh Arora Jean‐Francois Légaré
THE OPTIMAL TIMING OF CARDIAC SURGERY IN PATIENTS WITH INFECTIVE ENDOCARDITIS COMPLICATED BY STROKE
Debaters: Christopher Fordyce Christine Herman
THE ROLE OF CULPRIT ONLY PCI VS MULTIVESSEL CABG IN PATIENTS WITH CARDIOGENIC SHOCK WITH MULTIVESSEL DISEASE
Debaters: Ansar Hassan Mark Liszkowski
WRAP‐UP AND AUDIENCE QUESTIONS Sean Van Diepen
09:00 ‐ 10:00
Workshop
APPLYING THE 2019 CCS STEMI GUIDELINES TO CHALLENGING STEMI CASES
L'APPLICATION DES LIGNES DIRECTRICES SUR LE STEMI DE LA SCC (2019) AUX CAS DIFFICILES DE STEMI
CAD ACS & AMI
517C
Faculty: Warren Cantor Graham Wong Richard Vandegriend Joseph Minkowitz Michele Perry Arnesen Laurie Lambert Andrea Lavoie Matthew Sibbald Erin Rayner‐Hartley Sean Van Diepen Jacqueline Saw
Target Audience: Interventional cardiologists Critical care cardiologists and specialists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
select the best reperfusion therapy (primary PCI vs. fibrinolysis) for STEMI patients based on timing, setting and patient characteristics;
determine the most appropriate methods of transporting STEMI patients, and the role of adjunct therapy (including oxygen, opiates and antiplatelet therapy) in the ambulance; and
optimize their regional STEMI networks to enable rapid diagnosis and treatment of STEMI, and to provide routine early PCI after fibrinolysis.
Last updated: October 7, 2019
61
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
09:00 ‐ 10:00
Workshop
FINDING YOUR FOOTING ON THE HILL: ADVOCACY 101 FOR WANNABE INFLUENCERS
ÉTABLIR UNE POSITION D'INFLUENCE : INTRODUCTION À LA DÉFENSE DES INTÉRÊTS POUR LES INFLUENCEURS EN HERBE
PLCY
520AD
Chair: Chris Simpson
Presenters: Catherine Kells Manuel Arango Judith Seidman Isabelle Nault
Target Audience: General: All cardiovascular (clinical and research) health professionals Learning Objectives At the end of this session participants will be able to:
identify key decision makers and decision influencers and describe how they can lend their voice and support to a cause;
list effective strategies to use and pitfalls to avoid when advocating for a cause; and
identify the most appropriate messages and mechanisms to show support for a cause; and
describe tools, strategies and resources for an advocacy campaign.
09:00 ‐ 10:00
Workshop
IMAGING IN CARDIAC AMYLOIDOSIS, WHAT THE CARDIOLOGIST SHOULD KNOW. JOINT SESSION CSE/CANSCMR/CNCT
L'IMAGERIE DANS LES CAS D'AMYLOÏDOSE CARDIAQUE, CE QUE LE CARDIOLOGUE DOIT SAVOIR. SÉANCE CONJOINTE SCE/SCRMC/SCCNT.
IMAG HF CSE CANSCMR CNCT
517D
Faculty: Nowell Fine Davinder Jassal Francois Tournoux Sarah Blissett Gary Small Margot Davis
Target Audience: Echocardiologists Magnetic imaging specialist Nuclear and CT imaging specialist
Learning Objectives At the end of this session participants will be able to:
know when to suspect the diagnosis of amyloidosis from an echocardiogram;
understand the additional value of cardiac MRI and nuclear imaging for the diagnosis of cardiac amyloidosis; and
identify the key imaging parameters used for the follow‐up of patients with cardiac amyloidosis.
09:00 ‐ 10:00
Last updated: October 7, 2019
62
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Workshop
THE FUTURE OF HEART TRANSPLANTATION IN CANADA IS HERE! WHAT DO YOU KNOW ABOUT DONATION AFTER CIRCULATORY DEATH?
L'AVENIR DE LA TRANSPLANTATION CARDIAQUE AU CANADA EST À NOS PORTES! QUE SAVEZ‐VOUS DU DON D'ORGANE APRÈS DÉCÈS CIRCULATOIRE?
HF SURG
520BE
Faculty: Nicolas Noiseux Vivek Rao Roberto Ribeiro Mitesh Badiwala Dave Nagpal Sam Shemie Filio Billia Mark Kearns Anique Ducharme Nadia Bouabdallaoui Rakesh Arora Simon Maltais Yoan Lamarche
Target Audience: Cardiac transplant specialists Critical care cardiologists and specialists Academic cardiovascular health professionals and researchers
Learning Objectives At the end of this session participants will be able to:
understand the importance of DCD heart transplantation and describe the current pathways available for this donor population;
learn about the advantages and disadvantages of Ex Situ Heart Perfusion and future research needs; and
differentiate between direct procurement and perfusion and normothermic regional perfusion for procurement of hearts donated after circulatory death.
09:30 ‐ 16:30
Networking
CCC 2019 COMMUNITY FORUM OPEN
OUVERTURE DU FORUM COMMUNAUTAIRE DU CCSC 2019
NETWORKING
Community Forum, Level 200
Visit the CCC 2019 Community Forum with ePosters, Moderated Presentations, Affiliate Limelight Sessions, Community Forum Theater Sessions, the MIT Lounge, the FCCS Lounge, the Nurses Corner, and our amazing CCC 2019 Exhibitors!
10:00 ‐ 10:30 HEALTH BREAK, EPOSTER PRESENTATIONS, MODERATED PRESENTATIONS, COMMUNITY FORUM THEATRE AND EXHIBITION
PAUSE SANTÉ, PRÉSENTATIONS DES AFFICHES ÉLECTRONIQUES, PRÉSENTATIONS DIRIGÉES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
10:30 ‐ 11:00 CACPR: CARDIOVASCULAR GUIDELINES UPDATES
Last updated: October 7, 2019
63
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
ACPRC : MISE À JOUR DES LIGNES DIRECTRICES CARDIOVASCULAIRES
CACPR PREV
522
Faculty: Roberto Ribeiro
10:30 ‐ 11:30 BUILDING YOUR BEST CV
RÉDIGER LE MEILLEUR CV POSSIBLE
TRAINEE GENERAL
Trainee Lounge, Community Forum
Faculty: Christopher Labos Toronto, Ontario Maral Ouzounian Toronto, Ontario Ryan Perry Edmonton, Alberta Shelley Zieroth Winnipeg, MB
10:30 ‐ 11:30 MULTIMODALITY IMAGING
L'IMAGERIE MULTIMODALE
TRAINEE CARDIOLOGY
524C
Faculty: Gabrielle Horne Halifax, Nova Scotia Davinder Jassal Winnipeg, Manitoba Robert Moss Vancouver, British Columbia
Wendy Tsang Toronto, Ontario
Target Audience: Trainee (clinical) Trainee (research)
10:30 ‐ 11:30
PACEMAKER/ICD SESSION: ADVANCED
SÉANCE STIMULATEURS CARDIAQUES/DÉFIBRILLATEURS IMPLANTABLES: NIVEAU AVANCÉ
TRAINEE CARDIOLOGY
524A
Faculty: Ciorsti MacIntyre Halifax, Nova Scotia
Target Audience: Trainee (clinical) Trainee (research)
10:30 ‐ 11:30
Guidelines
2019 CCS POSITION STATEMENT ON RECENT INTERNATIONAL GUIDELINES ON THE ASSESSMENT AND MANAGEMENT OF SYNCOPE
ÉNONCÉ DE POSITION 2019 DE LA SCC SUR LES RÉCENTES LIGNES DIRECTRICES INTERNATIONALES EN MATIÈRE D'ÉVALUATION ET DE PRISE EN CHARGE DE LA SYNCOPE
EP GUIDELINE EDU
Last updated: October 7, 2019
64
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
517C
Faculty: Roopinder Sandhu Robert Sheldon Venkatesh Thiruganasambandamoorthy Andrew Krahn Satish Raj
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists
Learning Objectives At the end of this session participants will be able to:
compare and contrast the recently published international syncope guidelines;
describe how recommendations from these documents impact healthcare delivery and clinical practice in Canada; and
describe practical tips for the assessment and management of syncope.
10:30 ‐ 11:30
Workshop
TALES AND MYSTERIES FROM THE CATH LAB
RÉCITS DES MYSTÈRES ET AVENTURES DU LABORATOIRE DE CATHÉRISME
CAD GEN CAD ACS & AMI CAIC
520AD
Faculty: Malek Kass Hung Ly Derek So
Kunal Minhas Alexis Matteau
Target Audience: General: All cardiovascular (clinical and research) health professionals Interventional cardiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
discuss options for antithrombotic therapy in patients post angioplasty (in stable angina and ACS);
discuss imaging modalities for calcific coronary artery disease; and
review novel techniques in interventional approaches to patients with complex calcific coronary artery disease.
10:30 ‐ 12:00 CSCS BEST ABSTRACTS ORAL SESSION II
SÉANCE DES MEILLEURS RÉSUMÉS DE LA SCCC II
SURG CSCS
519A
Target Audience: Cardiac surgeons Cardiac surgery residents 10:30 263 PICK YOUR CONDUIT WISELY TO DECREASE GRAFT FAILURE AFTER CABG SURGERY Presenter: Mariam Alboom
Last updated: October 7, 2019
65
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
10:45 264 PREVENTION AND MANAGEMENT OF SPINAL CORD ISCHEMIA FOLLOWING AORTIC SURGERY: A NATIONWIDE SURVEY Presenter: Jennifer Chung 11:15 266 LONG‐TERM SURVIVAL IMPACT OF CONCOMITANT MITRAL VALVE INTERVENTION IN PATIENTS WITH SEVERE AORTIC STENOSIS AND FUNCTIONAL MITRAL REGURGITATION UNDERGOING AORTIC VALVE REPLACEMENT Presenter: Emile Voisine 11:30 267 AN ADAPTED CLAVIEN‐DINDO CLASSIFICATION AND COMPREHENSIEV COMPLICATIONS INDEX RELIABLY REPRESENT EARLY POSTOPERATIVE OUTCOMES IN CARDIAC SURGERY Presenter: Mélanie Hébert 11:45 268 APILLARY MUSCLE RELOCATION WITH A MULTI‐LOOP TECHNIQUE AS AN ADJUNCT FOR TREATMENT OF ISCHEMIC MITRAL REGURGITATION Presenter: Maria Theresa Dela Servito
10:30 ‐ 12:00 BENCH TO BEDSIDE: HOW TO TRANSLATE YOUR SCIENTIFIC DISCOVERY INTO PUBLIC BENEFIT?
DU LABORATOIRE AU CHEVET DES PATIENTS : COMMENT VOUS ASSURER QUE L'APPLICATION DE VOTRE DÉCOUVERTE SCIENTIFIQUE DÉBOUCHERA SUR UN BIENFAIT D'INTÉRÊT PUBLIC?
TRAINEE RESEARCH
524B
Faculty: Shurjeel Choudhri Toronto, Ontario Patrick Lawler Toronto, Ontario Peter Skarsgard Vancouver, British Columbia
Target Audience: Trainee (clinical) Trainee (research)
10:30 ‐ 12:00
Guidelines
CCS/CCTN POSITION STATEMENT ON HEART TRANSPLANT PATIENT ELIGIBILITY, SELECTION, AND POST‐TRANSPLANT CARE
ÉNONCÉ DE POSITION CONJOINT DE LA SCC/RCTC SUR L'ADMISSIBILITÉ, LA SÉLECTION ET LES SOINS POST‐GREFFE DES PATIENTS DE GREFFE CARDIAQUE
HF GUIDELINES
520BE
Faculty: Brian Clarke Sharon Chih
Last updated: October 7, 2019
66
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Michael McDonald Anique Ducharme
Target Audience: General: All cardiovascular (clinical and research) health professionals Cardiac transplant specialists Heart failure specialists Learning Objectives At the end of this session participants will be able to:
discuss patient selection criteria for heart transplantation, as defined in the 2019 CCS HTx Position Statement;
identify transplant issues for selected patient populations, including combined organ transplant, ACHD, and highly sensitized; and
discuss post‐transplant surveillance management.
10:30 ‐ 12:00
Plenary
CCS/ESC JOINT WORKSHOP: MANAGING COMPLEX ARRHYTHMIAS
ATELIER CONJOINT DE LA SCC/ESC : LA PRISE EN CHARGE DES ARYTHMIES COMPLEXES
EP ESC
517D
Co‐Chairs: Chiara Bucciarelli‐Ducci Andrew Krahn
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists
CATHETER ABLATION IN AF: WHEN, HOW AND WHO?
Presenter: Laurent Macle Montréal, Québec
PRECISION MEDICINE IN COMPLEX ARRHYTHMIAS
Presenter: Christian Steinberg Québec, Québec
ROLE OF MULTIMODALITY IMAGING IN ATRIAL FIBRILLATION
Presenter: Jeroen Bax Leiden, Netherlands
THE NEW 2019 ESC GUIDELINES ON SUPRAVENTRICULAR TACHYCARDIA
Presenter: Elena Arbelo Barecelona, Spain
10:30 ‐ 12:00
Plenary
JEAN‐CLAUDE FOURON SYMPOSIUM: STUMP THE EXPERTS ‐ BORDERLINE FINDINGS IN FETAL CARDIOLOGY
SYMPOSIUM JEAN‐CLAUDE FOURON : LAISSEZ L'EXPERT SANS VOIX – LES CAS LIMITES EN CARDIOLOGIE FŒTALE
CONG CPCA
518C
Last updated: October 7, 2019
67
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Faculty: Kenny Wong Lynne Nield Lisa Hornberger Jean‐Luc Bigras Jane Lougheed Felicia Nordenstam
Target Audience: Pediatric cardiologists
10:30 ‐ 12:00
Workshop
CANADIAN ADULT CONGENITAL HEART NETWORK SPOTLIGHT: ECHOCARDIOGRAPHY PEARLS: IMAGING CONGENITAL HEART DISEASE
SÉANCE VEDETTE DU RÉSEAU CANADIEN DES CARDIOPATHIES CONGÉNITALES DE L’ADULTE : LES PERLES D'ÉCHOCARDIOGRAPHIE : L'IMAGERIE DES CARDIOPATHIES CONGÉNITALES
CONG CACHNET IMAG
520CF
Co‐Chairs: Luc Beauchesne Jasmine Grewal
Planning Committee Member: Frederic Dallaire
Target Audience: Echocardiologists Adult congenital cardiologists Pediatric cardiologists
Learning Objectives At the end of this session participants will be able to:
identify and describe common unrepaired congenital heart disease;
systematically image the right ventricle in congenital heart disease; and
differentiate between “normal” and “abnormal” imaging parameters in repaired congenital heart disease.
10:30
RECOGNIZING UNREPAIRED CONGENITAL HEART DISEASES
Presenter: Claudia Renaud Montréal, Québec
11:00
EVALUATION OF COMMON SURGICAL REPAIRS FOR CONGENITAL HEART DISEASE
Presenter: Robin Ducas Winnipeg, Manitoba
11:30
IMAGING THE RIGHT VENTRICLE IN CONGENITAL HEART DISEASE
Presenter: Michelle Keir Calgary, Alberta
11:00 ‐ 12:00 CACPR: WOMEN CARDIAC REHABILITATION
ACPRC : LA RÉADAPTATION CARDIAQUE CHEZ LES FEMMES
Last updated: October 7, 2019
68
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
CACPR PREV
522
12:00 ‐ 14:00 LUNCH BREAK, EPOSTER VIEWING, COMMUNITY FORUM THEATRE AND EXHIBITION
PAUSE DÎNER, VISIONNEMENT DES AFFICHES ÉLECTRONIQUES, THÉÂTRE DU FORUM COMMUNAUTAIRE ET EXPOSITION
NETWORKING
Community Forum, Level 200
12:00 ‐ 14:00
Networking
TRAINEE NETWORKING LUNCHEON AND CAREER FAIR
LE DÎNER DE RÉSEAUTAGE DES STAGIAIRES ET FOIRE DE L'EMPLOI
TRAINEE GENERAL
516ABC
Ticketed event, must purchase in advance.
Host: William McIntyre
Target Audience: Trainee (clinical) Trainee (research)
12:30 ‐ 13:30
Accredited Symposium
THE GREAT DEBATE: ASPIRIN, DAPT OR DPI FOR SECONDARY PREVENTION IN STABLE ASCVD PATIENTS?
LE GRAND DÉBAT : L'ASPIRINE, LA BITHÉRAPIE ANTIPLAQUETTAIRE OU LA DPI POUR LES BESOINS DE LA PRÉVENTION SECONDAIRE CHEZ LES PATIENTS ATTEINTS DE CARDIOPATHIE DE L'ARTÉRIOSCLÉROSE?
CAD GEN CSI EDU CLINICAL CARDIOLOGY
517C
This event is an accredited Group Learning Activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was co‐developed with the Canadian Cardiovascular Society and Bayer Inc. and was planned to achieve scientific integrity, objectivity and balance. This program was made possible through an educational grant from Bayer Inc.
Click here to view the program!
Co‐Chairs: Shamir Mehta Jacob Udell
Planning Committee Members: Eva Lonn Jean‐Francois Tanguay Robert Welsh Graham Wong
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists Internists
Last updated: October 7, 2019
69
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Learning Objectives At the end of this session participants will be able to:
recognize the risk of recurrent events in patients with atherosclerotic cardiovascular disease using case‐based scenarios;
assess the appropriateness of long‐term antithrombotic regimen options for different patient types by reviewing the most recent evidence available; and
determine which patients should be transitioned from DAPT to the COMPASS regimen.
12:30
WELCOME AND INTRODUCTIONS
Presenter: Shamir Mehta
12:35
IT'S TIME TO OVERCOME INERTIA IN "STABLE" ATHEROSCLEROTIC CV DISEASE
Presenter: Eva Lonn
Learning Objectives At the end of this session participants will be able to:
recognize and quantify the risk of recurrent events in patients with atherosclerotic cardiovascular disease.
12:40
DEBATE: BE IT RESOLVED, IN STABLE ASCVD PATIENTS, IS ASPIRIN ENOUGH?
Presenters: Jacob Udell Robert Welsh
Learning Objectives At the end of this session participants will be able to:
understand the benefits and risks of aspirin, dual pathway inhibition, or dual antiplatelet therapy as the top line long‐term antithrombotic therapy in stable patients.
12:50
CASE STUDY: CHRONIC CAD
Presenter: Graham Wong
Learning Objectives At the end of this session participants will be able to:
define the optimal long‐term antithrombotic regimen for stable patients with coronary artery disease.
12:55
INTERACTIVE PANEL DISCUSSION AND LIVE AUDIENCE Q&A
Presenter: Shamir Mehta
13:08
CASE STUDY: POST‐ACS WITH STENT
Presenter: Jean‐Francois Tanguay
Learning Objectives At the end of this session participants will be able to:
define the optimal long‐term antithrombotic regimen for stable patients post‐ACS who underwent PCI with stenting.
Last updated: October 7, 2019
70
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
13:13
INTERACTIVE PANEL DISCUSSION AND LIVE AUDIENCE Q&A (VIA PARTICIPANT’S MOBILES)
Presenter: Shamir Mehta
13:25
CLOSING REMARKS
Presenter: Shamir Mehta
14:00 ‐ 15:00 PLANNING YOUR RESEARCH CAREER: LIFE AFTER THE PHD
LA PLANIFICATION DE VOTRE CARRIÈRE EN RECHERCHE : LA VIE APRÈS LE DOCTORAT
TRAINEE RESEARCH
524B
Faculty: Steve Arless Montréal Rakesh Arora Winnipeg, Manitoba Samuel Lichtenstein Vancouver, British Columbia Ryan Perry Edmonton, Alberta
Target Audience: Trainee (research)
14:00 ‐ 15:00
Plenary
YEAR IN REVIEW ‐ PRIMARY AND SECONDARY PREVENTION IN CVD
RÉTROSPECTIVE DE L’ANNÉE ‐ LA PRÉVENTION PRIMAIRE ET SECONDAIRE DES MCV
GENERAL CLINICAL CARDIOLOGY TRAINEE
220CDE ‐ Plenary Room via CF
Chair: David Bewick
Co‐Chair: Michelle Graham
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
14:00
PRIMARY PREVENTION‐ASA, SUPPLEMENTS AND TRIGLYCERIDES
Presenter: G.B. John Mancini Vancouver, British Columbia
14:00
SECONDARY PREVENTION WITH “CARDIO‐DIABETES”
Presenter: Subodh Verma Toronto, Ontario
14:00 ‐ 15:00
Workshop
CRITICAL CARE CARDIOLOGY TRAINING PATHWAYS
PARCOURS DE FORMATION EN CARDIOLOGIE POUR LES MALADES EN PHASE CRITIQUE
Last updated: October 7, 2019
71
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
CAD ACS & AMI TRAINEE CARDIOLOGY CAD GEN
524C
Faculty: Barry Burstein Joshua Wenner Maude Peretz‐Larochelle Toronto, Ontario Erin Rayner‐Hartley Cleveland, Ohio Lior Bibas Montréal, Québec Sean Van Diepen Edmonton, Alberta Michael Goldfarb Montréal, Québec Richard Vandegriend New Westminster, British Columbia Emilie P Belley‐Côté Hamilton, Ontario
Target Audience: Trainee (clinical) Critical care cardiologists and specialists General: All cardiovascular (clinical and research) health professionals
Learning Objectives At the end of this session participants will be able to:
outline the contribution of the critical care cardiology skill set to contemporary practice in the CICU;
identify the potential roles of a critical care cardiologist in the current framework of local, regional, and national cardiovascular care in Canada, as defined by CCS; and
outline the CCS‐endorsed training pathways and opportunities in Canada and the United States.
14:00 ‐ 15:00
Workshop
LA STÉNOSE AORTIQUE SÉVÈRE ASYMPTOMATIQUE : MYTHE OU RÉALITÉ ?
LA STÉNOSE AORTIQUE SÉVÈRE ASYMPTOMATIQUE : MYTHE OU RÉALITÉ?
CSI
520CF
Faculty: Jessica Forcillo Philippe Généreux Hélène Mayrand Josée Morin Vicky Soulière Benoit Daneault Richard Essiambre Igal Sebag Catherine Bourque Benoit M‐Labbé
Target Audience: Clinical cardiologists Cardiac surgeons Interventional cardiologists
Learning Objectives At the end of this session participants will be able to:
apprécier le rôle pronostique de l'épreuve à l'effort chez le patient dit asymptomatique;
reconnaître l'évolution de la sténose aortique asymptomatique; and
Last updated: October 7, 2019
72
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
choisir le moment opportun pour référer les patients pour un remplacement valvulaire aortique.
14:00 ‐ 15:00
Workshop
TALES AND MYSTERIES FROM THE CATH LAB
RÉCITS DES MYSTÈRES ET AVENTURES DU LABORATOIRE DE CATHÉRISME
CAD GEN CAD ACS & AMI CAIC
520AD
Faculty: Malek Kass Hung Ly Derek So Kunal Minhas Alexis Matteau
Target Audience: General: All cardiovascular (clinical and research) health professionals Interventional cardiologists Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
discuss options for antithrombotic therapy in patients post angioplasty (in stable angina and ACS);
discuss imaging modalities for calcific coronary artery disease; and
review novel techniques in interventional approaches to patients with complex calcific coronary artery disease.
14:00 ‐ 15:30 CSCS BEST ABSTRACTS ORAL SESSION III
SÉANCE DES MEILLEURS RÉSUMÉS DE LA SCCC III
SURG CSCS
519A
Target Audience: Cardiac surgeons Cardiac surgery residents 14:00 269 WHAT DOES GENETIC TESTING TELLS US ABOUT OUTCOMES IN PATIENTS UNDERGOING SEPTAL MYECTOMY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY? Presenter: Vincent Chauvette 14:15 270 IS THE ROSS PROCEDURE A COST‐EFFECTIVE ALTERNATIVE COMPARED TO MECHANICAL AORTIC VALVE REPLACEMENT IN NON‐ELDERLY PATIENTS WITH AORTIC STENOSIS? Presenter: Sara Hussain 14:30 271 CONTEMPORARY OUTCOMES OF AORTIC AND MITRAL VALVE SURGERY FOR RHEUMATIC HEART DISEASE IN SUB‐SAHARAN AFRICA Presenter: Amine Mazine
Last updated: October 7, 2019
73
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
14:45 272 THE IMPACT OF PRE‐OPERATIVE FRAILTY ON THE COST OF ADULT CARDIAC SURGERY IN ALBERTA: A PROSPECTIVE COHORT STUDY Presenter: Carmel Montgomery 15:00 273 LEFT VENTRICULAR APEX FIBROELASTOMA Presenter: Luca Revelli
14:00 ‐ 15:30
Guidelines
STRENGTHENING TAVI BEST PRACTICES IN CANADA: UPDATED CCS POSITION STATEMENT AND QUALITY INITIATIVES
LE RENFORCEMENT DES PRATIQUES EXEMPLAIRES EN MATIÈRE DE TAVI AU CANADA : ÉNONCÉ DE POSITION MIS À JOUR DE LA SCC ET INITIATIVES EN MATIÈRE DE QUALITÉ
CSI CAD GEN SURG PLCY GUIDELINES QUALITY
520BE
Faculty: Anita Asgar Sandra Lauck Maral Ouzounian Harindra Wijeysundera
Laurie Lambert Malek Kass Corey Adams Robert Welsh Jonathan Afilalo
Target Audience: Cardiac surgeons, cardiologists and cardiovascular health professionals Trainees Health care administrators
Learning Objectives At the end of this session participants will be able to:
understand the changes and variation in measured TAVI quality since the inception of the TAVI Quality Report in 2016 to present day, and discuss strategies to overcome barriers to delivering care;
discuss the revision of the TAVI quality indicators and methods to collect data using existing data structures i.e., CIHI; and
describe the CCS recommendations regarding TAVI for patients undergoing TAVI in Canada;
distinguish clinical scenarios that should be considered by a multidisciplinary Heart Team when determining the recommendation for transcatheter or surgical aortic valve replacement; and
discuss the implications of expanding indications on the patient population with aortic stenosis including increased wait times and strategies to improve existing infrastructure.
14:00 ‐ 15:30
Plenary
Last updated: October 7, 2019
74
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
CPCA/CACH JOINT SYMPOSIUM III‐ CONGENITAL AORTIC STENOSIS THROUGHOUT THE LIFESPAN
SYMPOSIUM CONJOINT DE L'ACCP ET DU RCCCA III ‐ LE RÉTRÉCISSEMENT AORTIQUE CONGÉNITAL PENDANT TOUTE LA VIE
CONG CPCA CACH
518C
Co‐Chair: Luc Beauchesne
Target Audience: Adult congenital cardiologists Pediatric cardiologists
14:00
AORTIC STENOSIS IN THE FETUS AND NEONATE – HOW TO ASSESS SEVERITY AND PREDICT PROGNOSIS
Presenter: Angela McBrien Edmonton, Alberta
14:25
WHY AND WHEN SHOULD WE BE CONSIDERING PERCUTANEOUS INTERVENTION IN CHILDREN, TEEN AND YOUNG ADULTS
Presenter: Adrian Dancea Montréal, Québec
14:45
WHY AND WHEN SHOULD WE BE CONSIDERING SURGERY IN CHILDREN AND YOUNG ADULTS
Presenter: Frédéric Jacques Québec, Québec
15:05
LONG‐TERM OUTCOME OF CONGENITAL SEVERE AORTIC STENOSIS
Presenter: Judith Therrien Montréal, Québec
14:00 ‐ 15:30
Workshop
CANADIAN HEART RHYTHM SOCIETY SPOTLIGHT: CURRENT CONTROVERSIES IN ICDS AND PACEMAKERS
SÉANCE VEDETTE DE LA SOCIÉTÉ CANADIENNE DE RYTHMOLOGIE : LES DÉBATS ACTUELS RELATIFS AUX DÉFIBRILLATEURS IMPLANTABLES ET AUX STIMULATEURS CARDIAQUES
EP CHRS
517C
Faculty: Matthew Bennett Ratika Parkash Stephen Wilton Vikas Kuriachan Blandine Mondesert Pablo Nery Andrew Ha Calum Redpath Bernard Thibault Larry Sterns François Philippon Derek Exner
Last updated: October 7, 2019
75
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Target Audience: Electrophysiologists General: All cardiovascular (clinical and research) health professionals Heart failure specialists
Learning Objectives At the end of this session participants will be able to:
understand how the presence of atrial fibrillation affects the risk/benefit decision of the use of cardiac resynchronization therapy in patients with left bundle branch block, reduced ejection fraction and heart failure symptoms;
appreciate the differences between subcutaneous and transvenous implantable cardioverter defibrillators and understand which strategy may be beneficial over the other; and
understand in which patients a leadless pacemaker may be preferred over a standard pacemaker.
14:00 ‐ 15:30
Workshop
CANADIAN SOCIETY OF ECHOCARDIOGRAPHY SPOTLIGHT: NO LONGER IGNORED ‐ TRICUSPID VALVE IMAGING AND INTERVENTION
SÉANCE VEDETTE DE LA SOCIÉTÉ CANADIENNE D'ÉCHOCARDIOGRAPHIE : UNE RÉALITÉ QUI A PRIS SA PLACE, L'IMAGERIE ET LES INTERVENTIONS VISANT LA VALVE TRICUSPIDE
IMAG CSE
517D
Faculty: Lawrence Rudski
Usha Manian Howard Leong‐Poi Wendy Tsang Kwan Chan Paaladinesh Thavendiranathan David Messika‐Zeitoun Emmanuel Moss Geraldine Ong Robert Moss
Target Audience: Echocardiologists Cardiac surgeons Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
better understand tricuspid valve anatomy and suitability for tricuspid valve interventions;
accurately assess the mechanisms of tricuspid regurgitation and quantify the severity of tricuspid regurgitation; and
better understand the different therapies to address severe tricuspid regurgitation, the indications, strengths and weaknesses, including surgical and transcatheter techniques.
14:30 ‐ 15:30 CACPR: OLDER ADULTS CARDIAC REHABILITATION
ACPRC : LA RÉADAPTATION CARDIAQUE CHEZ LES PERSONNES ÂGÉES
CACPR PREV
522
Last updated: October 7, 2019
76
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
15:00 ‐ 16:00
Plenary
YEAR IN REVIEW ‐ MANAGING ATRIAL FIBRILLATION IN 2019 ‐ WHY IS IT SO COMPLICATED?
RÉTROSPECTIVE DE L’ANNÉE ‐ LA PRISE EN CHARGE DE LA FIBRILLATION AURICULAIRE EN 2019 – « POURQUOI EST‐CE SI COMPLIQUÉ? »
GENERAL CLINICAL CARDIOLOGY TRAINEE
220CDE ‐ Plenary Room via CF
Chair: David Bewick
Co‐Chair: Allan Skanes
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
15:00
EVOLVING APPROACHES IN DIAGNOSIS
Presenter: Jeff Healey Hamilton, Ontario
15:00
EVOLVING MANAGEMENT STRATEGIES
Presenter: Jason Andrade Vancouver, British Columbia
15:30 ‐ 16:30 RECEPTION
RÉCEPTION DES EXPOSANTS
NETWORKING
Community Forum, Level 200
16:00 ‐ 17:00
Plenary
YEAR IN REVIEW ‐ CVD DISORDERS‐UNDER DIAGNOSED AND MAYBE NOT SO RARE
RÉTROSPECTIVE DE L’ANNÉE ‐ TROUBLES DE MCV : SOUS‐DIAGNOSTIQUÉS ET PEUT‐ÊTRE PAS SI RARES
GENERAL CLINICAL CARDIOLOGY TRAINEE
220CDE ‐ Plenary Room via CF
Chair: David Bewick
Co‐Chair: Gillian Nesbitt
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners
16:00
CARDIAC AMYLOID
Presenter: Nowell Fine Calgary, Alberta
16:00
NON‐ATHEROSCLEROTIC MI‐NOT SO BENIGN...
Last updated: October 7, 2019
77
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Presenters: Karin Humphries Vancouver, British Columbia
Tara Sedlak Vancouver, British Columbia
16:30 ‐ 17:30 CARDIAC REHABILITATION THROUGHOUT THE LIFESPAN: WALKING THE DELICATE LINE
LA RÉADAPTATION CARDIAQUE PENDANT TOUTE LA VIE : UNE DÉMARCHE DES PLUS DÉLICATES
CACPR PREV
522
16:30 ‐ 17:30 Workshop
THE ATRIAL FIBRILLATION AND ARRHYTHMIA COLLOQUIUM 2019: SUPPORTING RESEARCH EXCELLENCE FOR THE NEXT GENERATION OF CANADIAN LEADERS
COLLOQUE 2019 SUR LA FIBRILLATION AURICULAIRE ET L'ARYTHMIE : SOUTENIR L'EXCELLENCE EN RECHERCHE POUR LA PROCHAINE GÉNÉRATION DE CHEFS DE FILE CANADIENS
GENERAL EP TRAINEE
520CF
Faculty: Ratika Parkash Glen Pearson Marc Deyell
Target Audience: General: All cardiovascular (clinical and research) health professionals Electrophysiologists Trainee (research and clinical)
Learning Objectives At the end of this session participants will be able to:
describe new research insights related to adherence with oral anticoagulants versus warfarin;
describe new findings related to risks of recurrent AF in non‐cardiac surgery patients; and
discuss emerging trends and critical research questions that will shape the future care of patients with cardiac arrhythmias.
16:30 ‐ 17:30 REVASCULARIZATION WITH MULTIVESSEL PCI FOR MYOCARDIAL INFARCTION: WE FINALLY HAVE THE COMPLETE ANSWER!
LA REVASCULARISATION PAR ICP MULTIVAISSEAUX DANS LES CAS D'INFARCTUS DU MYOCARDE : NOUS AVONS ENFIN LA RÉPONSE DÉFINITIVE QUE NOUS ATTENDIONS!
CSI CAIC
520AD
Faculty: David Wood Shamir Mehta John Cairns
Target Audience: General: All cardiovascular (clinical and research) health professionals
Last updated: October 7, 2019
78
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
Academic cardiovascular health professionals and researchers Clinical cardiologists Critical care cardiologists and specialists Interventional cardiologists
Learning Objectives At the end of this session participants will be able to:
understand the design, rationale, and results of the Canadian‐led and recently published COMPLETE Trial (NEJM 2019);
discuss when the benefit of complete revascularization on major cardiovascular events (cardiovascular death and new MI) occurs and how the timing of staged complete revascularization may impact clinical outcomes (JACC 2019);
describe the clinical implications for Canadian patients with STEMI and multivessel disease; and
understand the possible impact of COMPLETE on global ACS guidelines.
16:30 ‐ 17:30
Plenary
CPCA/CACH JOINT SYMPOSIUM IV ‐ STATE OF THE ART IN REHABILITATION OF THE RIGHT VENTRICULAR OUTFLOW TRACT
SYMPOSIUM CONJOINT DE L'ACCP ET DU RCCCA IV – LES TECHNIQUES DE POINTE EN MATIÈRE DE RÉADAPTATION DE LA CHAMBRE DE CHASSE DU VENTRICULE DROIT
CONG CPCA CACH
518C
Co‐Chairs: Jasmine Grewal Joaquim Miró
Target Audience: Adult congenital cardiologists Pediatric cardiologists
16:30
LATE OUTCOMES AFTER SURGICAL REPAIR OF THE RVOT: COMMON CLINICAL SCENARIOS
Presenter: Lucy Roche Toronto, Ontario
16:50
SURGICAL TECHNIQUES FOR RVOT REHABILITATION WITH SHORT‐TERM AND LONG‐TERM OUTCOMES
Presenter: Nancy Poirier Montréal, Québec
17:10
PERCUTANEOUS STRATEGIES FOR RVOT REHABILITATION, INCLUDING PULMONARY VALVE IMPLANTATION IN CONDUITS AND NATIVE RVOTS
Presenter: Mounir Riahi Vancouver, British Columbia
16:30 ‐ 17:30
Workshop
SURGICAL THE YEAR IN REVIEW
COMPÉTENCES CHIRURGICALES, RÉTROSPECTIVE DE L'ANNÉE
Last updated: October 7, 2019
79
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
SURG CSCS
519A
Co‐Chairs: Philippe Demers Yoan Lamarche
Target Audience: Cardiac surgeons Cardiac surgery residents
16:30
IMPORTANT STRUCTURAL SURGICAL PAPERS
Presenter: Philippe Demers
16:30
IMPORTANT CORONARY ARTERY SURGICAL PAPERS
16:45
IMPORTANT CARDIAC ICU PAPERS
Presenter: Yoan Lamarche
16:30 ‐ 17:30
Workshop
THE HEART FAILURE CONTINUUM AND THE LIVED EXPERIENCE: PERSPECTIVES FROM DIAGNOSIS THROUGH TRANSPLANT AND BEYOND
LE CONTINUUM DE L'INSUFFISANCE CARDIAQUE ET DU VÉCU : DU DIAGNOSTIC À LA GREFFE ET AU‐DELÀ
HF PLCY
520BE
Faculty: Jillianne Code Heather Ross Marc Bains Tracy Bawtinheimer Sharon Bray Jackie Ratz Sunny Tutt Heather Lannon
Target Audience: Heart failure specialists General: All cardiovascular (clinical and research) health professionals Researchers
Learning Objectives At the end of this session participants will be able to:
identify the unique challenges patients and family carers face while living with a heart failure diagnosis, through listening to the stories of patient and family carer panelists currently living along the heart failure continuum;
comprehend the social, psychological, and economic impacts of living with heart failure from the perspective of the lived experience, by participating in an interactive panel question and answer period; and
empathize with the complexity of the lived experience of heart failure – from diagnosis through transplant – and recognize what they as practitioners, researchers, and clinicians can do to assist in the shared journey we all face.
16:30 ‐ 17:30
Workshop
Last updated: October 7, 2019
80
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Saturday, October 26, 2019
TRANSCATHETER MITRAL AND TRICUSPID INTERVENTIONS: READY FOR PRIME TIME?
LES INTERVENTIONS TRANSCATHÉTER VISANT LES VALVES MITRALE ET ATRIOVENTRICULAIRE DROITE : L'HEURE EST‐ELLE VENUE POUR LEUR UTILISATION GÉNÉRALISÉE?
HF SURG
517D
Faculty: Anique Ducharme Denis Bouchard Anita Asgar Neil Fam Rob Boone Luc Pham Sandra Lauck
Target Audience: General: All cardiovascular (clinical and research) health professionals Cardiac surgeons Heart failure specialists
Learning Objectives At the end of this session participants will be able to:
understand the clinical challenges of mitral and tricuspid regurgitation and treatment options;
understand the data supporting treatment of Functional mitral regurgitation; and
understand clinical indications for transcatheter treatment of mitral and tricuspid regurgitation.
16:30 ‐ 17:30
Workshop
WOMEN IN CARDIOVASCULAR MEDICINE AND SCIENCE: PAST, PRESENT, AND FUTURE
LE PASSÉ, LE PRÉSENT ET L’AVENIR DES FEMMES EN MÉDECINE ET SCIENCE CARDIOVASCULAIRES
PLCY EDU
517C
Faculty: Laura Banks Varinder Randhawa Michelle Graham Kim Connelly Sharon Straus Michael Sean McMurtry Savita Dhanvantari Linda Palmer Lisa Robinson Carolyn Pullen
Target Audience: General: All cardiovascular (clinical and research) health professionals Trainee (research) Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
recognize the accomplishments of Canadian women in cardiovascular medicine and science;
identify current trends and initiatives regarding gender equity in cardiovascular medicine and science related careers; and
apply strategies and/or methods that promote gender equity within their institution and scope of practice.
Last updated: October 7, 2019
81
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
07:00 ‐ 15:00
Plenary
CARDIOGENIC SHOCK DAY
JOURNÉE DU CHOC CARDIOGÉNIQUE
HF CSI SURG CANCARE CHFS CCTN CAIC CSCS TRAINEE
517C
Co‐Chairs: Yoan Lamarche Shelley Zieroth
Planning Committee Members: Annie Bédard Lior Bibas Jean‐Bernard Breau Brian Clarke Anique Ducharme Nicole Dubyk Anil Gupta Jean‐Francois Légaré Hung Ly Valérie Rodgers
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists
Learning Objectives At the end of this session participants will be able to:
identify patients with cardiogenic shock;
describe investigation and initial treatment of ischemic and non ischemic cardiogenic shock; and
describe organization of cardiogenic shock response teams in Canada;
discuss algorithms and decision making for temporary mechanical support for cardiogenic shock; and
participate in case based simulation for cardiogenic shock.
07:00
BREAKFAST
07:30
CARDIOGENIC SHOCK DAY OPENING REMARKS & INTRODUCTIONS
Presenter: Anique Ducharme Montréal, Québec
07:45
CARDIOGENIC SHOCK YEAR‐IN‐REVIEW
Presenter: Sean Van Diepen Edmonton, Alberta
08:30
EMERGENCY ROOM IDENTIFICATION OF CARDIOGENIC SHOCK
Presenter: Dominic Larose Montréal, Québec
09:00
MEDICAL MANAGEMENT OF CARDIOGENIC SHOCK
Last updated: October 7, 2019
82
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
Presenter: Gordan Samoukovic Montréal, Québec
09:40
DESCRIPTION OF PHYSIOLOGY OF MECHANICAL SUPPORT AND AVAILABLE DEVICES
Presenter: Jean‐Bernard Breau Montréal, Québec
10:00
HEALTH BREAK
10:30
SHOCK TEAM ‐ CANADIAN EXPERIENCE
Chair: Brian Clarke Calgary, Alberta
Presenters: Sharon Chih Ottawa, Ontario
Gordan Samoukovic Montréal, Québec Karim Serri Montréal, Québec
11:25
PLANNING A SAFE TRANSPORT FOR THE CARDIOGENIC SHOCK PATIENT
Presenters: Anil Gupta Mississauga, Ontario Mark Liszkowski Montréal, Québec
11:50
MORNING SESSION CONCLUSION & LUNCH BOX PICKUP
517C
12:10
DEBATE: MY DEVICE IS BIGGER THAN YOURS, BUT MINE PROVIDES BETTER RELIEF!
Co‐Chairs: Yoan Lamarche Montréal, Québec
Shelley Zieroth Winnipeg, Manitoba
Debaters: Daniel Kim Edmonton, Alberta
Gurmeet Singh Edmonton, Alberta
13:15
HANDS ON SMALL GROUP SESSION – ECMO/CARDIOHELP
520BE
Presenters: Nicole Dubyk Edmonton, Alberta
Fanny Lange Montréal, Québec Emilie Levesque Montréal, Québec
Dave Nagpal London, Ontario
Last updated: October 7, 2019
83
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
Learning Objectives At the end of this session participants will be able to:
review the clinical indications for each device;
understand the technical considerations of implementation; and
review troubleshooting algorithms for commonly occurring clinical scenarios.
13:15
HANDS ON SMALL GROUP SESSION – IMPELLA
5518C
Presenters: Anique Ducharme Montréal, Québec
Annie Bédard Vancouver, British Columbia
Hung Ly Montréal, Québec
Learning Objectives At the end of this session participants will be able to:
review the clinical indications for each device;
understand the technical considerations of implementation; and
review troubleshooting algorithms for commonly occurring clinical scenarios.
13:15
HANDS ON SMALL GROUP SESSION – TANDEM HEART
520CF
Presenters: Francine Guilbault Montréal, Québec
Yoan Lamarche Montréal, Québec
Learning Objectives At the end of this session participants will be able to:
review the clinical indications for each device;
understand the technical considerations of implementation; and
review troubleshooting algorithms for commonly occurring clinical scenarios.
14:00
SIMULATION AS A TOOL TO ENHANCE CARE OF A CARDIOGENIC SHOCK PATIENT: HOW DO I GET BETTER OUTCOMES IN MY HOSPITAL
Presenter: Nicolas Thibodeau‐Jarry Montréal, Québec
14:20
INTER AND INTRA HOSPITAL TRANSPORT OF ECMO PATIENTS
Presenter: Fanny Lange Montréal, Québec
14:40
CARDIOGENIC SHOCK DAY CLOSING REMARKS
Last updated: October 7, 2019
84
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
Co‐Chairs: Anique Ducharme Montréal, Québec
Yoan Lamarche Montréal, Québec
08:00 ‐ 09:00
Workshop
PUBLIC REPORTING OF CARDIAC SURGICAL OUTCOMES IN CANADA: FURTHER AHEAD OR FURTHER BEHIND?
LES RAPPORTS PUBLICS SUR LES RÉSULTATS DE CHIRURGIE CARDIAQUE AU CANADA : UN BOND EN AVANT OU EN ARRIÈRE?
SURG PLCY QUALITY
520CF
Faculty: Ansar Hassan Colleen Norris Jim Abel Karin Humphries Laurie Lambert Vivek Rao Maral Ouzounian Gregory Hirsch Jean‐Francois Légaré
Target Audience: General: All cardiovascular (clinical and research) health professionals Researchers
Learning Objectives At the end of this session participants will be able to:
distinguish between clinical (observational) and administrative data registries and the strengths and weaknesses of each in reporting cardiac surgical outcomes in Canada;
assess the efficacy of various risk‐adjustment models in accounting for differences in patient populations; and
determine the impact of public report cards on cardiac surgery outcomes in Canada and formulate the need for public reporting of cardiac surgical outcomes in Canada.
09:00 ‐ 10:00
Plenary
STUMP THE EXPERTS
LAISSEZ L'EXPERT SANS VOIX
SURG EP CAD ACS & AMI TRAINEE
517D
Co‐Chairs: Christopher Cheung Michelle Graham
Panelists: Matthew Bennett Denis Bouchard Wendy Tsang
Target Audience: Trainee (clinical) Trainee (research)
09:00
PANHYPOPITUITARISM AFTER A TRICUSPID VALVE INFECTIOUS ENDOCARDITIS: A CASE REPORT
Last updated: October 7, 2019
85
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
Presenter: Nawal Amhis Blainville, Québec
09:20
PSEUDOANEURYSM OF THORACIC AORTA PRESENTING AS INAPPROPRIATE SINUS TACHYCARDIA AND CHRONIC COUGH: A CASE REPORT
Presenter: Zahra Azizi Newmarket, Ontario
09:40
AN UNUSUAL CASE OF NON SMALL CELL LUNG CANCER PRESENTING AS NON‐ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
Presenter: Umar Sharif Khawaja Newark, New Jersey
09:00 ‐ 10:00
Workshop
#HERHEARTMATTERS: IMPROVING OUTCOMES IN WOMEN WITH CARDIOVASCULAR DISEASE
#LECOEURDESFEMMESESTIMPORTANT : AMÉLIORER LES RÉSULTATS CHEZ LES FEMMES ATTEINTES D’UNE MALADIE CARDIOVASCULAIRE
CAD GEN EDU
520BE
Co‐Chairs: Sharon Mulvagh April Pike
Presenters: Carolyn Baer
Harriette Van Spall Helena Van Ryn Martha Mackay Maral Ouzounian Nadia Lappa Martha Gulati Jessica Forcillo
Planning Committee Members: Judy Luu Anita Pozgay Michele Turek Kajenny Srivaratharajah Samantha Berschdt Rudy Unni Najah Adreak Beth Abramson
Target Audience: General: All cardiovascular (clinical and research) health professionals Academic cardiovascular health professionals and researchers Trainee (clinical)
Learning Objectives At the end of this session participants will be able to:
understand the role and mission of the Canadian Women’s Heart Health Alliance;
recognize the risk factors that predispose women to heart disease; and
review the spectrum of ischemic heart disease, including SCAD, in women; and
identify sex‐specific disparities in heart failure and cardiac surgery and review strategies to improve outcomes.
09:00
WOMEN AND HEART DISEASE IN CANADA: INTRODUCING CWHHA
Last updated: October 7, 2019
86
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
Presenter: Helena Van Ryn
09:05
RISK FACTORS FOR HEART DISEASE IN WOMEN
Presenter: Martha Mackay
09:10
SPECTRUM OF ISCHEMIC HEART DISEASE IN WOMEN: UNIQUE CHALLENGES AND OPPORTUNITIES
Presenter: Martha Gulati
09:17
SCAD ‐ PATIENT AND PHYSICIAN PERSPECTIVES
Presenters: Nadia Lappa Carolyn Baer
09:27
DISPARITIES IN HEART FAILURE CARE AND OUTCOMES: CLOSING THE GAP
Presenter: Harriette Van Spall
09:34
SEX‐SPECIFIC CONSIDERATION IN CV SURGERY: STRATEGIES TO IMPROVE OUTCOMES
Presenters: Maral Ouzounian Jessica Forcillo
09:41
DISCUSSION AND Q&A
09:00 ‐ 11:35
Plenary
JOINT CPCA/CPCHRN PEDIATRIC ELECTROPHYSIOLOGY COURSE
COURS CONJOINT ACCP/CPCHRN D'ÉLECTROPHYSIOLOGIE PÉDIATRIQUE
CONG EP CPCA
518C
Chair: Anne Fournier
Target Audience: Pediatric cardiologists
09:00
ECG MELTING POT – INTERACTIVE SESSION WITH AUDIENCE PARTICIPATION
Presenter: Sylvia Abadir Montréal, Québec
09:20
VENTRICULAR ARRHYTHMIAS ‐ WHAT THE PEDIATRIC CARDIOLOGIST SHOULD KNOW ABOUT VENTRICULAR ARRHYTHMIAS (PVC AND VT) IN PATIENTS WITHOUT INHERITED ARRHYTHMIAS OR STRUCTURAL HEART DISEASE
Presenter: Virginie Beausejour Ladouceur Toronto, Ontario
09:40
Last updated: October 7, 2019
87
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
LONG QT ‐ WHAT THE PEDIATRIC CARDIOLOGIST SHOULD KNOW ABOUT LONG QT SYNDROME
Presenter: Audrey Dionne Montréal, Québec
10:00
BREAK
10:30
WPW ‐ WHAT THE PEDIATRIC CARDIOLOGIST SHOULD KNOW ABOUT ASYMPTOMATIC WPW
Presenter: Jean‐Marc Côté Québec, Québec
10:50
WHAT THE PEDIATRIC CARDIOLOGIST SHOULD KNOW ABOUT MRI CONDITIONAL CIED (CARDIAC IMPLANTABLE ELECTRONIC DEVICES)
Presenter: Anica Bulic Toronto, Ontario
11:10
EP STUDIES ‐ WHAT THE PEDIATRIC CARDIOLOGIST SHOULD KNOW ABOUT ELECTROPHYSIOLOGY STUDIES
Presenter: Carolina Escudero Edmonton, Alberta
11:30
CLOSING REMARKS
Co‐Chairs: Anne Fournier Montréal, Québec
Joseph Atallah Edmonton, Alberta
10:00 ‐ 10:30 HEALTH BREAK
PAUSE SANTÉ ET EXPOSITION
NETWORKING
517 Lobby
10:30 ‐ 12:00
Guidelines
GUIDELINES RAPID REVIEW
SURVOL DES LIGNES DIRECTRICES DE LA SCC
GUIDELINES
517D
Chair: Michael Sean McMurtry
Target Audience: General: All cardiovascular (clinical and research) health professionals Clinical cardiologists General practitioners Learning Objectives At the end of this session participants will be able to:
summarize key messages from the CCS guideline/position statement workshops;
discuss emerging issues and evidence; and
Last updated: October 7, 2019
88
FINAL PROGRAM 2019 PROGRAMME DÉFINITIF
#CCCMTL
Sunday, October 27, 2019
identify resources designed to integrate CCS guidelines/position statements into practice.
10:30
2019 CCS POSITION STATEMENT ON RECENT INTERNATIONAL GUIDELINES ON THE ASSESSMENT AND MANAGEMENT OF SYNCOPE
EP EDU
Presenter: Roopinder Sandhu
10:45
CCS HEART FAILURE GUIDELINES: CLINICAL TRIALS UPDATE
HF CHFS
Presenter: Shelley Zieroth
11:00
STRENGTHENING TAVI BEST PRACTICES IN CANADA: UPDATED CCS POSITION STATEMENT AND QUALITY INITIATIVES
CSI CAD GEN SURG PLCY QUALITY
Presenters: Anita Asgar Maral Ouzounian
11:15
A PRACTICAL CASE‐BASED WORKSHOP ON THE 2018 FOCUSED UPDATE OF THE CCS
GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION
EP CAD GEN CHRS
Presenter: Jason Andrade
11:30
CCS POSITION STATEMENT ON POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
EP EDU
Presenter: Robert Sheldon
11:45
CCS/CCTN POSITION STATEMENT ON HEART TRANSPLANT PATIENT ELIGIBILITY, SELECTION, AND POST‐TRANSPLANT CARE
HF CCTN
Presenter: Brian Clarke
Last updated: October 7, 2019
89
Last updated: October 7, 2019
Recommended